BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Danan G, Teschke R. RUCAM in Drug and Herb Induced Liver Injury: The Update. Int J Mol Sci. 2015;17:14. [PMID: 26712744 DOI: 10.3390/ijms17010014] [Cited by in Crossref: 355] [Cited by in F6Publishing: 371] [Article Influence: 44.4] [Reference Citation Analysis]
Number Citing Articles
1 Huang D, Peng J, Lei L, Chen Y, Zhu Z, Cai Q, Deng Y, Chen J. Time of Liver Function Abnormal Identification on Prediction of the Risk of Anti-tuberculosis-induced Liver Injury. J Clin Transl Hepatol 2023;11:425-32. [PMID: 36643044 DOI: 10.14218/JCTH.2022.00077] [Reference Citation Analysis]
2 Ault TA, Braxton DR, Watson RA, Marcus AO, Fong TL. Mifepristone induced liver injury in a patient with Cushing syndrome: a case report and review of the literature. J Med Case Rep 2023;17:33. [PMID: 36732814 DOI: 10.1186/s13256-022-03696-x] [Reference Citation Analysis]
3 Kumagai K, Mawatari S, Moriuchi A, Oda K, Takikawa Y, Kato N, Oda S, Inoue K, Terai S, Genda T, Shimizu M, Sakaida I, Mochida S, Ido A. Early-phase prothrombin time-international normalized ratio in acute liver injury indicates the timing of therapeutic intervention and predicts prognostic improvement. Hepatol Res 2023;53:160-71. [PMID: 36301000 DOI: 10.1111/hepr.13848] [Reference Citation Analysis]
4 Malhotra K, Fazylov R, Friedman-Jakubovics M. A Case-Report of Drug-Induced Mixed Liver Injury Resulting From Cefepime Exposure. J Pharm Pract 2023;36:164-7. [PMID: 34098807 DOI: 10.1177/08971900211015046] [Reference Citation Analysis]
5 Asgarzdeh A, Habibzadeh S, Asghariazar V, Safarzadeh E. Drug-induced hepatitis (DIH) after SARS-CoV-2 vaccination. Clin Res Hepatol Gastroenterol 2023;47:102028. [PMID: 36195274 DOI: 10.1016/j.clinre.2022.102028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wang Q, Ma L, Sun B, Zhang A. Reduced Peripheral Blood Mitochondrial DNA Copy Number as Identification Biomarker of Suspected Arsenic-Induced Liver Damage. Biol Trace Elem Res 2023. [PMID: 36720785 DOI: 10.1007/s12011-023-03584-5] [Reference Citation Analysis]
7 Liu Z, Zhu Y, Xie H, Zou Z. Immune-mediated hepatitis induced by immune checkpoint inhibitors: Current updates and future perspectives. Front Pharmacol 2022;13:1077468. [PMID: 36699050 DOI: 10.3389/fphar.2022.1077468] [Reference Citation Analysis]
8 Liu Y, Li H, Huang L, Wan C, Wang H, Jiao X, Zeng L, Jia Z, Cheng G, Zhang L, Zhang W, Zhang L. Liver Injury in Children: Signal Analysis of Suspected Drugs Based on the Food and Drug Administration Adverse Event Reporting System.. [DOI: 10.21203/rs.3.rs-2435773/v1] [Reference Citation Analysis]
9 Meunier L, Larrey D. Hepatotoxicity of Drugs Used in Multiple Sclerosis, Diagnostic Challenge, and the Role of HLA Genotype Susceptibility. Int J Mol Sci 2023;24. [PMID: 36614299 DOI: 10.3390/ijms24010852] [Reference Citation Analysis]
10 Sunagawa SW, Houlihan C, Reynolds B, Kjerengtroen S, Murry DJ, Khoury N. Turmeric-Associated Drug-Induced Liver Injury. ACG Case Rep J 2022;9:e00941. [PMID: 36600786 DOI: 10.14309/crj.0000000000000941] [Reference Citation Analysis]
11 Teschke R. Treatment of Drug-Induced Liver Injury. Biomedicines 2022;11. [PMID: 36672522 DOI: 10.3390/biomedicines11010015] [Reference Citation Analysis]
12 Karlafti E, Paramythiotis D, Pantazi K, Georgakopoulou VE, Kaiafa G, Papalexis P, Protopapas AA, Ztriva E, Fyntanidou V, Savopoulos C. Drug-Induced Liver Injury in Hospitalized Patients during SARS-CoV-2 Infection. Medicina (Kaunas) 2022;58. [PMID: 36557050 DOI: 10.3390/medicina58121848] [Reference Citation Analysis]
13 Ma CD, Faust D, Bonkovsky HL. Idiosyncratic drug-induced liver injury caused by givosiran in a patient with acute intermittent porphyria. Mol Genet Metab Rep 2023;34:100946. [PMID: 36578356 DOI: 10.1016/j.ymgmr.2022.100946] [Reference Citation Analysis]
14 Gao Q, Yin X, Tan B, Wang J, Chen J, Zhao B, Yang Q, Li Z. Drug-induced liver injury following the use of tocilizumab or sarilumab in patients with coronavirus disease 2019. BMC Infect Dis 2022;22:929. [PMID: 36503381 DOI: 10.1186/s12879-022-07896-0] [Reference Citation Analysis]
15 Kim J, Jang W. Safety of prescribed herbal medicines for hepatic and renal function of polypharmacy patients with stroke: A single-center retrospective study. Medicine (Baltimore) 2022;101:e32147. [PMID: 36482592 DOI: 10.1097/MD.0000000000032147] [Reference Citation Analysis]
16 Ashraf A, Daloya J, Barnes M, Ansari U, Ashraf N, Lee H, Caruso R. Alpelisib-induced acute cholestatic hepatitis in a patient with metastatic breast cancer- a case report. Current Problems in Cancer: Case Reports 2022;8:100200. [DOI: 10.1016/j.cpccr.2022.100200] [Reference Citation Analysis]
17 He T, Ren L, Gong M, Guo Y, Wang L, Xiao X, Wang R, Bai Z. The progression of chronicity and autoimmune hepatitis in recurrent drug-induced liver injury. Clin Res Hepatol Gastroenterol 2022;46:102009. [PMID: 35977662 DOI: 10.1016/j.clinre.2022.102009] [Reference Citation Analysis]
18 Ouchi R, Kashiwagura S, Watanabe T, Usui K, Ito J, Kaiho Y, Sato M, Okada K. Pazopanib-Induced Liver Injury in Patients With Metastatic Renal Cell Carcinoma: A Report of Two Cases. Cureus 2022;14:e32474. [PMID: 36644081 DOI: 10.7759/cureus.32474] [Reference Citation Analysis]
19 Wang MG, Wu SQ, Zhang MM, He JQ. Urine metabolomics and microbiome analyses reveal the mechanism of anti-tuberculosis drug-induced liver injury, as assessed for causality using the updated RUCAM: A prospective study. Front Immunol 2022;13:1002126. [PMID: 36483548 DOI: 10.3389/fimmu.2022.1002126] [Reference Citation Analysis]
20 Ma Z, Shi Z, Xiao X, Wang J. New insights into herb-induced liver injury. Antioxidants & Redox Signaling 2022. [DOI: 10.1089/ars.2022.0134] [Reference Citation Analysis]
21 Qiu X, Ren B, Lian Y, Fang L, Dong Z. Acute liver injury induced by drug interaction between dacomitinib and metoprolol due to the inhibition of CYP2D6 by dacomitinib. J Oncol Pharm Pract 2022. [DOI: 10.1177/10781552221139773] [Reference Citation Analysis]
22 Schmidt M, Thomsen M, Kuchta K. Kava Kava-Associated Acute Liver Failure? Am J Ther 2022;29:e729-31. [PMID: 33416242 DOI: 10.1097/MJT.0000000000001240] [Reference Citation Analysis]
23 Koshy A, Mahadevan P, Mukkada RJ, Francis JV, Chettupuzha AP, Augustine P. Spectrum of drug-induced liver injury in a tertiary hospital in southern India. NMJI 2022;35:78-81. [DOI: 10.25259/nmji_112_19] [Reference Citation Analysis]
24 Swanson LA, Kassab I, Tsung I, Schneider BJ, Fontana RJ. Liver injury during durvalumab-based immunotherapy is associated with poorer patient survival: A retrospective analysis. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.984940] [Reference Citation Analysis]
25 Hou W, Nsengimana B, Yan C, Nashan B, Han S. Involvement of endoplasmic reticulum stress in rifampicin-induced liver injury. Front Pharmacol 2022;13:1022809. [DOI: 10.3389/fphar.2022.1022809] [Reference Citation Analysis]
26 Shen K, Gu Y, Wang Y, Lu Y, Ni Y, Zhong H, Shi Y, Su X. Therapeutic drug monitoring and safety evaluation of voriconazole in the treatment of pulmonary fungal diseases. Ther Adv Drug Saf 2022;13:20420986221127503. [PMID: 36225945 DOI: 10.1177/20420986221127503] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Zafar M, Gordon K, Macken L, Parvin J, Heath S, Whibley M, Tibble J. COVID-19 Vaccination-Induced Cholangiopathy and Autoimmune Hepatitis: A Series of Two Cases. Cureus 2022;14:e30304. [PMID: 36258805 DOI: 10.7759/cureus.30304] [Reference Citation Analysis]
28 Monge-Urrea F, Montijo-Barrios E. Drug-induced Liver Injury in Pediatrics. J Pediatr Gastroenterol Nutr 2022;75:391-5. [PMID: 35727646 DOI: 10.1097/MPG.0000000000003535] [Reference Citation Analysis]
29 Kajiwara A, Kawamura Y, Kinowaki K, Muraishi N, Iritani S, Akuta N, Fujiyama S, Sezaki H, Hosaka T, Saitoh S, Kobayashi M, Arase Y, Ikeda K, Suzuki F, Suzuki Y, Kumada H. A case of drug-induced acute liver failure caused by corticosteroids. Clin J Gastroenterol 2022;15:946-952. [DOI: 10.1007/s12328-022-01661-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Lee H, Kim H, Kim K, Cho J, Song M, Chung W. Effectiveness and safety of Korean medicine for pain management after musculoskeletal surgery: a retrospective study. ADV TRADIT MED (ADTM) 2022. [DOI: 10.1007/s13596-022-00660-4] [Reference Citation Analysis]
31 Shao YL, Ma CM, Wu JM, Guo FC, Zhang SC. Concurrent severe hepatotoxicity and agranulocytosis induced by Polygonum multiflorum: A case report. World J Clin Cases 2022; 10(27): 9921-9928 [DOI: 10.12998/wjcc.v10.i27.9921] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Gao Q, Yin X, Tan B, Wang J, Chen J, Yang Q, Zhao B, Li Z. Drug-induced liver injury following the use of tocilizumab or sarilumab in patients with coronavirus disease 2019.. [DOI: 10.21203/rs.3.rs-1986289/v1] [Reference Citation Analysis]
33 Fu L, Qian Y, Shang Z, Sun X, Kong X, Gao Y. Antibiotics enhancing drug-induced liver injury assessed for causality using Roussel Uclaf Causality Assessment Method: Emerging role of gut microbiota dysbiosis. Front Med 2022;9. [DOI: 10.3389/fmed.2022.972518] [Reference Citation Analysis]
34 Deng H, Lin H, Mai Y, Liu H, Chen W. Clinical features and predictive factors related to liver injury in SARS-CoV-2 Delta and Omicron variant-infected patients. Eur J Gastroenterol Hepatol 2022;34:933-9. [PMID: 35482929 DOI: 10.1097/MEG.0000000000002381] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
35 Bai Z, Tao W, Zhou Y, Cao Y, Yu S, Shi Z. Xiao-Yao-San protects against anti-tuberculosis drug-induced liver injury by regulating Grsf1 in the mitochondrial oxidative stress pathway. Front Pharmacol 2022;13:948128. [DOI: 10.3389/fphar.2022.948128] [Reference Citation Analysis]
36 Naseralallah LM, Aboujabal BA, Geryo NM, Al Boinin A, Al Hattab F, Akbar R, Umer W, Abdul Jabbar L, Danjuma MI. The determination of causality of drug induced liver injury in patients with COVID-19 clinical syndrome. PLoS ONE 2022;17:e0268705. [DOI: 10.1371/journal.pone.0268705] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Li D, Dong J, Xi X, Huang G, Li W, Chen C, Liu J, Du Q, Liu S. Impact of pharmacist active consultation on clinical outcomes and quality of medical care in drug-induced liver injury inpatients in general hospital wards: A retrospective cohort study. Front Pharmacol 2022;13:972800. [DOI: 10.3389/fphar.2022.972800] [Reference Citation Analysis]
38 Roth RA, Kana O, Filipovic D, Ganey PE. Pharmacokinetic and toxicodynamic concepts in idiosyncratic, drug-induced liver injury. Expert Opin Drug Metab Toxicol 2022;:1-13. [PMID: 36003040 DOI: 10.1080/17425255.2022.2113379] [Reference Citation Analysis]
39 Mannocchi G, Tittarelli R, Pantano F, Vernich F, Pallocci M, Passalacqua P, Treglia M, Marsella LT. Forensic Aspects of a Fatal Intoxication Involving Acetaminophen, Citalopram and Trazodone: A Case Report. Toxics 2022;10:486. [PMID: 36006165 DOI: 10.3390/toxics10080486] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Zhao W, Li Y, Xie R, Dong Y, Wei Y, Cheng C, Lowe S, Sun C, Wang C, Gao J, Cui D. Real-World Evidence for COVID-19 Delta Variant’s Effects on the Digestive System and Protection of Inactivated Vaccines from a Medical Center in Yangzhou, China: A Retrospective Observational Study. International Journal of Clinical Practice 2022;2022:1-9. [DOI: 10.1155/2022/7405448] [Reference Citation Analysis]
41 Plüß M, Tampe D, Schwörer H, Bremer SCB, Tampe B. Case report: Kinetics of human leukocyte antigen receptor HLA-DR during liver injury induced by potassium para-aminobenzoate as assessed for causality using the updated RUCAM. Front Pharmacol 2022;13:966910. [DOI: 10.3389/fphar.2022.966910] [Reference Citation Analysis]
42 Lopes dos Santos A, Lagarto M, Gouveia C. A Rare Case of Intravenous Amiodarone Toxicity. Cureus 2022. [DOI: 10.7759/cureus.27958] [Reference Citation Analysis]
43 D’errico S, Zanon M, Radaelli D, Concato M, Padovano M, Scopetti M, Frati P, Fineschi V. Acute Kidney Injury (AKI) in Young Synthetic Cannabinoids Abusers. Biomedicines 2022;10:1936. [DOI: 10.3390/biomedicines10081936] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Kawase A, Takashima O, Tanaka S, Shimada H, Iwaki M. Diclofenac-Induced Cytotoxicity in Direct and Indirect Co-Culture of HepG2 Cells with Differentiated THP-1 Cells. IJMS 2022;23:8660. [DOI: 10.3390/ijms23158660] [Reference Citation Analysis]
45 Atallah E, Oshaughnessy A, Dolapo I, Moore Y, Ntata J, Rao A, Franks H, Patel PM, Aithal GP. Prescription Event Monitoring of Checkpoint Inhibitor-Induced Liver Injury and Outcomes of Rechallenge: A 10-Year Experience. EMJ Hepatol 2022. [DOI: 10.33590/emjhepatol/10057736] [Reference Citation Analysis]
46 Kim S, Kim H, Kang D, Ko J, Kim J, Kim K, Kim B, Cho J, Song M, Chung W. Hepatic and Renal Safety of Concurrent Use of Conventional and Herbal Medications for Musculoskeletal Disorders: A Retrospective Observational Study. J Korean Med Rehabil 2022;32:131-140. [DOI: 10.18325/jkmr.2022.32.3.131] [Reference Citation Analysis]
47 Qasim Agha O, Al Hennawi H, Alani M, Aslam S, Reynolds J. Anabolic Steroid-Induced Cholestatic Liver Injury: A Case Report. Cureus 2022. [DOI: 10.7759/cureus.27514] [Reference Citation Analysis]
48 Dijmărescu I, Guță OM, Brezeanu LE, Dijmărescu AD, Becheanu CA, Păcurar D. Drug-Induced Hepatitis in Children: The Experience of a Single Center in Romania. Children 2022;9:1136. [DOI: 10.3390/children9081136] [Reference Citation Analysis]
49 Liu Y, Li C, Shen X, Liu Y. The use of traditional Chinese medicines in relieving exercise-induced fatigue. Front Pharmacol 2022;13:969827. [DOI: 10.3389/fphar.2022.969827] [Reference Citation Analysis]
50 Yang R, Li K, Zou C, Wee A, Liu J, Liu L, Li M, Wu T, Wang Y, Ma Z, Wang Y, Liu J, Huang A, Sun Y, Chang B, Liang Q, Jia J, Zou Z, Zhao X. Alanine Aminotransferase and Bilirubin Dynamic Evolution Pattern as a Novel Model for the Prediction of Acute Liver Failure in Drug-Induced Liver Injury. Front Pharmacol 2022;13:934467. [DOI: 10.3389/fphar.2022.934467] [Reference Citation Analysis]
51 Wiebrecht A. Bei Psoraleae fructus (Buguzhi) an eine mögliche Hepatotoxizität denken! Chinese Medicine 2022;37:94-105. [DOI: 10.1007/s00052-022-00052-6] [Reference Citation Analysis]
52 Hayashi PH, Lucena MI, Fontana RJ, Bjornsson ES, Aithal GP, Barnhart H, Gonzalez-Jimenez A, Yang Q, Gu J, Andrade RJ, Hoofnagle JH. A revised electronic version of RUCAM for the diagnosis of DILI. Hepatology 2022;76:18-31. [PMID: 35014066 DOI: 10.1002/hep.32327] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 17.0] [Reference Citation Analysis]
53 Björnsson HK, Sverrisdottir A, Björnsson ES. Dili is rare amongst patients without liver metastases receiving cancer treatment in Iceland: a population-based cohort study. Scand J Gastroenterol 2022;57:856-61. [PMID: 35138984 DOI: 10.1080/00365521.2022.2038260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Teschke R, Eickhoff A. Editorial: chronic DILI and HILI - corticosteroid plus glycyrrhizin as standard therapy? Aliment Pharmacol Ther 2022;56:166-7. [PMID: 35689326 DOI: 10.1111/apt.16943] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Lewis JH. Digitizing DILI: Who can? RUCAM? RECAM? Hepatology 2022;76:3-5. [PMID: 34990036 DOI: 10.1002/hep.32312] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Wang N, Guo S, Liu H, Ding Y, Yao R, Liu Z, Zhu H, Chen X, Yang X, Chen X, Lu Y. Relevance of gene polymorphisms of NAT2 and NR1I2 to anti-tuberculosis drug-induced hepatotoxicity. Xenobiotica 2022;:1-7. [PMID: 35723590 DOI: 10.1080/00498254.2022.2092783] [Reference Citation Analysis]
57 Liu Y, Guo Y, Xu H, Feng H, Chen D. Anxiety and Its Influencing Factors in Patients With Drug-Induced Liver Injury. Front Psychol 2022;13:889487. [DOI: 10.3389/fpsyg.2022.889487] [Reference Citation Analysis]
58 Wang N, Chen X, Hao Z, Yi H, Tang S. Association of ABCG2 polymorphisms with susceptibility to anti-tuberculosis drug-induced hepatotoxicity in the Chinese population. Xenobiotica 2022;:1-18. [PMID: 35735268 DOI: 10.1080/00498254.2022.2093685] [Reference Citation Analysis]
59 Wurzburger R. A Case of Delayed Hepatic Injury Associated with Teriflunomide Use as Assessed for Causality Using the Updated RUCAM. Case Reports in Hepatology 2022;2022:1-3. [DOI: 10.1155/2022/6331923] [Reference Citation Analysis]
60 Brelje A, Fay B, Mariouw S, Vandenberg A. Identifying olanzapine induced liver injury in the setting of acute hepatitis C: A case report. Mental Health Clinician 2022;12:210-3. [DOI: 10.9740/mhc.2022.06.210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Zhu L, Geng J, Xiao A. Drug-induced severe liver injury due to Sterculia versicolor: a case report with causality assessment from possible to probable. J Biomed Res 2022;36:215-20. [PMID: 35965441 DOI: 10.7555/JBR.36.20220044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Weber S, Gerbes AL. Challenges and Future of Drug-Induced Liver Injury Research-Laboratory Tests. Int J Mol Sci 2022;23:6049. [PMID: 35682731 DOI: 10.3390/ijms23116049] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 An Z, Sun Y, Shi C, Liu L. Metabonomic and transcriptomic analyses of Tripterygium glycosides tablet-induced hepatotoxicity in rats. Drug Chem Toxicol 2022;:1-15. [PMID: 35603506 DOI: 10.1080/01480545.2022.2077360] [Reference Citation Analysis]
64 Edamana SN, Hegde S, Vasudevan R. Letter to the editor: Concerning the paper entitled "TC (Giloy) induced liver injury…" by Anand Kulkarni et al. Hepatol Commun 2022. [PMID: 35503793 DOI: 10.1002/hep4.1978] [Reference Citation Analysis]
65 Ardila-Suárez OM, Oriz-Benjumea L, Arteta AA, Guevara-Casallas LG. Drug-induced liver injury: Relation between the R ratio and histopathology. Rev Gastroenterol Mex (Engl Ed) 2022:S2255-534X(22)00019-6. [PMID: 35523682 DOI: 10.1016/j.rgmxen.2022.03.006] [Reference Citation Analysis]
66 Wang JB, Huang A, Wang Y, Ji D, Liang QS, Zhao J, Zhou G, Liu S, Niu M, Sun Y, Tian H, Teng GJ, Chang BX, Bi JF, Peng XX, Xin S, Xie H, Ma X, Mao YM, Liangpunsakul S, Saxena R, Aithal GP, Xiao XH, Zhao J, Zou Z. Corticosteroid plus glycyrrhizin therapy for chronic drug- or herb-induced liver injury achieves biochemical and histological improvements: a randomised open-label trial. Aliment Pharmacol Ther 2022;55:1297-310. [PMID: 35362188 DOI: 10.1111/apt.16902] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
67 Liu W, Wang N, Zhu J, Zhang M, Lu L, Pan H, He X, Yi H, Tang S. The relationship between relative telomere length and anti-tuberculosis drug-induced hepatitis : A case-control study. Therapies 2022. [DOI: 10.1016/j.therap.2022.05.007] [Reference Citation Analysis]
68 Zhou Z, Yin X, Zhang Y, Shao Q, Mao X, Hu W, Shen Y, Zhao B, Li Z. Antifungal Drugs and Drug-Induced Liver Injury: A Real-World Study Leveraging the FDA Adverse Event Reporting System Database. Front Pharmacol 2022;13:891336. [DOI: 10.3389/fphar.2022.891336] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
69 Teschke R, Méndez-Sánchez N, Eickhoff A. Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method. Int J Mol Sci 2022;23:4828. [PMID: 35563242 DOI: 10.3390/ijms23094828] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
70 Liu W, Lu L, Pan H, He X, Zhang M, Wang N, Zhu J, Yi H, Tang S. Haem oxygenase-1 and haemopexin gene polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity in China. Pharmacogenomics 2022. [PMID: 35470713 DOI: 10.2217/pgs-2022-0015] [Reference Citation Analysis]
71 Zhang M, Zhu J, Wang N, Liu W, Lu L, Pan H, He X, Yi H, Tang S. The role of the genetic variant FECH rs11660001 in the occurrence of anti-tuberculosis drug-induced liver injury. J Clin Pharm Ther 2022. [PMID: 35470464 DOI: 10.1111/jcpt.13672] [Reference Citation Analysis]
72 Delladetsima K, Manesis E, Tiniakos D, Sakellariou S. Complex liver injury induced by combined Aloe Vera and vitamin A oral supplements, as assessed by histology and the updated RUCAM. Exploration of Medicine. [DOI: 10.37349/emed.2022.00084] [Reference Citation Analysis]
73 Yao L, Zhang J, Jin J, Li H, Li L, Han X, Raza HK, Li X, Mao Y. An analysis of the efficacy and safety of compound glycyrrhizin injections in the treatment of drug-induced liver injury using a nationwide database. Int J Clin Pharm 2022. [PMID: 35438473 DOI: 10.1007/s11096-022-01402-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Wang Z, Ma J, Yao S, He Y, Miu KK, Xia Q, Fu PP, Ye Y, Lin G. Liquorice Extract and 18β-Glycyrrhetinic Acid Protect Against Experimental Pyrrolizidine Alkaloid-Induced Hepatotoxicity in Rats Through Inhibiting Cytochrome P450-Mediated Metabolic Activation. Front Pharmacol 2022;13:850859. [PMID: 35370657 DOI: 10.3389/fphar.2022.850859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Kohn OF, Lew SQ, Wong SS, Sam R, Chen HC, Raiman JG, Leehey DJ, Tzamaloukas AH, Ing TS. Using herbs medically without knowing their composition: are we playing Russian roulette? Curr Med Res Opin 2022;:1-10. [PMID: 35362342 DOI: 10.1080/03007995.2022.2061706] [Reference Citation Analysis]
76 Hermann RP, Rockey DC, Suzuki A, Merz M, Tillmann HL. A novel phenotype-based drug-induced liver injury causality assessment tool (DILI-CAT) allows for signal confirmation in early drug development. Aliment Pharmacol Ther 2022;55:1028-37. [PMID: 35266155 DOI: 10.1111/apt.16836] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
77 Rao A, Rule JA, Hameed B, Ganger D, Fontana RJ, Lee WM. Secular Trends in Severe Idiosyncratic Drug-Induced Liver Injury in North America: An Update From the Acute Liver Failure Study Group Registry. Am J Gastroenterol 2022;117:617-26. [PMID: 35081550 DOI: 10.14309/ajg.0000000000001655] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
78 Qin F, Sang G, Zou X, Cheng D, Marasco G. Drug-Induced Liver Injury during Consolidation Therapy in Childhood Acute Lymphoblastic Leukemia as Assessed for Causality Using the Updated RUCAM. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-9. [DOI: 10.1155/2022/5914593] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
79 Tzadok R, Levy S, Aouizerate J, Shibolet O, Machado MCC. Acute Liver Failure following a Single Dose of Atezolizumab, as Assessed for Causality Using the Updated RUCAM. Case Reports in Gastrointestinal Medicine 2022;2022:1-4. [DOI: 10.1155/2022/5090200] [Reference Citation Analysis]
80 Soares PF, Fernandes MTCF, Souza AS, Lopes CM, Dos Santos DAC, Oliveira DPR, Pereira MG, Prado NMBL, Gomes GSDS, Santos G Junior, Paraná R. Causality imputation between herbal products and HILI: An algorithm evaluation in a systematic review. Ann Hepatol 2021;25:100539. [PMID: 34555512 DOI: 10.1016/j.aohep.2021.100539] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Ghorbani H, Rouhi T, Vosough Z, Shokri-Shirvani J. Drug-induced hepatitis after Sinopharm COVID-19 vaccination: A case study of a 62-year-old patient. Int J Surg Case Rep 2022;93:106926. [PMID: 35284210 DOI: 10.1016/j.ijscr.2022.106926] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
82 Liu S, Zhou Y, Wang Y, Li CB, Wang W, Lu X, Liu P, Hu QH, Wen Y. The Correlated Risk Factors for Severe Liver Damage Among HIV-Positive Inpatients With Abnormal Liver Tests. Front Med (Lausanne) 2022;9:817370. [PMID: 35273978 DOI: 10.3389/fmed.2022.817370] [Reference Citation Analysis]
83 Rodríguez A, García-garcía I, Martínez de Soto L, Gómez López De Las Huertas A, Borobia AM, González-torbay A, Akatbach-bousaid I, González-muñoz M, Ramírez E. Utility of Lymphocyte Transformation Test for Assisting Updated Roussel Uclaf Causality Assessment Method in Drug-Induced Liver Injury: A Case-Control Study. Front Pharmacol 2022;13:819589. [DOI: 10.3389/fphar.2022.819589] [Reference Citation Analysis]
84 Sakar O, Teker T, Nak SG, Uğraş N. Indomethacin induced toxic hepatitis: a case report. Turkish Journal of Internal Medicine. [DOI: 10.46310/tjim.1072846] [Reference Citation Analysis]
85 Scoazec JY. Drug-induced bile duct injury: new agents, new mechanisms. Curr Opin Gastroenterol 2022;38:83-8. [PMID: 34931623 DOI: 10.1097/MOG.0000000000000813] [Reference Citation Analysis]
86 Ardila-suárez O, Oriz-benjumea L, Arteta A, Guevara-casallas L. Daño hepático inducido por medicamentos: relación entre el índice R y la histopatología. Revista de Gastroenterología de México 2022. [DOI: 10.1016/j.rgmx.2021.03.008] [Reference Citation Analysis]
87 Wang Y, Gou Y, Zhang L, Li C, Wang Z, Liu Y, Geng Z, Shen M, Sun L, Wei F, Zhou J, Gu L, Jin H, Ma S. Levels and Health Risk of Pesticide Residues in Chinese Herbal Medicines. Front Pharmacol 2021;12:818268. [PMID: 35177984 DOI: 10.3389/fphar.2021.818268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
88 Studentova H, Volakova J, Spisarova M, Zemankova A, Aiglova K, Szotkowski T, Melichar B. Severe tyrosine-kinase inhibitor induced liver injury in metastatic renal cell carcinoma patients: two case reports assessed for causality using the updated RUCAM and review of the literature. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02121-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
89 Falcão D, Pedroto I, Moreira T. The wide phenotypic and genetic spectrum of ABCB4 gene deficiency: A case series. Dig Liver Dis 2022;54:221-7. [PMID: 34376370 DOI: 10.1016/j.dld.2021.07.003] [Reference Citation Analysis]
90 Nunes DRDCMA, Monteiro CSDJ, dos Santos JL. Herb-Induced Liver Injury—A Challenging Diagnosis. Healthcare 2022;10:278. [DOI: 10.3390/healthcare10020278] [Reference Citation Analysis]
91 Chen J, Wu H, Tang X, Chen L. 4-Phenylbutyrate protects against rifampin-induced liver injury via regulating MRP2 ubiquitination through inhibiting endoplasmic reticulum stress. Bioengineered 2022;13:2866-77. [PMID: 35045794 DOI: 10.1080/21655979.2021.2024970] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
92 Blanquicett A, Martinez-ávila MC, Mondol Z, Imbeth Acosta P. Toxic Hepatitis Associated With the Use of Contraceptives: A Diagnosis to Bear in Mind. Cureus 2022. [DOI: 10.7759/cureus.21220] [Reference Citation Analysis]
93 Cao Y, Liu M, Wu S, Xu J, Wang W, Qi X, Ren J, Sun J, Chen J, Gong L. Kupffer cells play a crucial role in monocrotaline-induced liver injury by producing TNF-α. Toxicology 2022. [DOI: 10.1016/j.tox.2022.153101] [Reference Citation Analysis]
94 Teschke R, Danan G. Causality Assessment in Pharmacovigilance for Herbal Medicines. Pharmacovigilance for Herbal and Traditional Medicines 2022. [DOI: 10.1007/978-3-031-07275-8_10] [Reference Citation Analysis]
95 Balkrishna A, Bhattacharya K, Sinha S, Dev R, Srivastava J, Singh P, Haldar S, Varshney A. Apparent Hepatotoxicity of Giloy (Tinospora cordifolia): Far From What Meets the Eyes. J Clin Exp Hepatol 2022;12:239-40. [PMID: 35068809 DOI: 10.1016/j.jceh.2021.09.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
96 Savage RL. The Value of Complementary Approaches to Causality Assessment for Individual Case Safety Reports: The Example of Artemisia annua and Hepatotoxicity. Pharmacovigilance for Herbal and Traditional Medicines 2022. [DOI: 10.1007/978-3-031-07275-8_11] [Reference Citation Analysis]
97 Maksimova E, Kliaritskaia I, Grigorenko E, Moshko Y. Prevention and treatment of drug-induced liver injury in patients with breast cancer and ovarian cancer. NAMJ 2022. [DOI: 10.56936/18290825-2022.16.3-78] [Reference Citation Analysis]
98 Atallah E, Aithal GP. Drug-Induced Liver Injury. In Clinical Practice 2022. [DOI: 10.1007/978-3-031-10012-3_3] [Reference Citation Analysis]
99 Ilchenko LY, Fedorov IG, Totolyan GG, Karelina AM, Sedova GA, Finkelberg GE, Termosesova EY, Nikitin IG. Hyperenzymemia after vaccination against COVID-19: complex equation with simple variables. jour 2021. [DOI: 10.31146/1682-8658-ecg-194-10-159-164] [Reference Citation Analysis]
100 Ye L, Feng Z, Huang L, Guo C, Wu X, He L, Tan W, Wang Y, Wu X, Hu B, Li T, Yang G, Chengxian G, He Q. Causality Evaluation of Drug-Induced Liver Injury in Newborns and Children in the Intensive Care Unit Using the Updated Roussel Uclaf Causality Assessment Method. Front Pharmacol 2021;12. [DOI: 10.3389/fphar.2021.790108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
101 Suh HW, Seol JH, Bae EJ, Kwak HY, Hong S, Park YS, Lim JH, Chung SY. Effectiveness and Safety of the Korean Medicine Senior Health Promotion Program Using Herbal Medicine and Acupuncture for Mild Cognitive Impairment: A Retrospective Study of 500 Patients in Seoul, Korea. Evid Based Complement Alternat Med 2021;2021:8820705. [PMID: 34912467 DOI: 10.1155/2021/8820705] [Reference Citation Analysis]
102 Pais JP, Mota R, Cruz M, Cambão AR, Nascimento A. Drug-Induced Liver Injury Induced by Bioflavonoids. Cureus 2021. [DOI: 10.7759/cureus.20453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
103 Shah T, Joslyn JA, Lai J. Ceftazidime induced liver injury. BMJ Case Rep 2021;14:e246571. [PMID: 34887294 DOI: 10.1136/bcr-2021-246571] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
104 Chen Z, Jiang Y, Zhang X, Zheng R, Qiu R, Sun Y, Zhao C, Shang H. ResNet18DNN: prediction approach of drug-induced liver injury by deep neural network with ResNet18. Brief Bioinform 2021:bbab503. [PMID: 34882224 DOI: 10.1093/bib/bbab503] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
105 Khan Z, Karataş Y, Kıroğlu O. Evaluation of Adverse Drug Reactions in Paediatric Patients: A Retrospective Study in Turkish Hospital. Front Pharmacol 2021;12:786182. [PMID: 34867419 DOI: 10.3389/fphar.2021.786182] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
106 Shi X, Zuo C, Yu L, Lao D, Li X, Xu Q, Lv Q. Real-World Data of Tigecycline-Associated Drug-Induced Liver Injury Among Patients in China: A 3-year Retrospective Study as Assessed by the Updated RUCAM. Front Pharmacol 2021;12:761167. [PMID: 34795591 DOI: 10.3389/fphar.2021.761167] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
107 Stati G, Rossi F, Sancilio S, Basile M, Di Pietro R. Curcuma longa Hepatotoxicity: A Baseless Accusation. Cases Assessed for Causality Using RUCAM Method. Front Pharmacol 2021;12:780330. [PMID: 34776989 DOI: 10.3389/fphar.2021.780330] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
108 Liu W, Zeng X, Liu Y, Liu J, Li C, Chen L, Chen H, Ouyang D. The Immunological Mechanisms and Immune-Based Biomarkers of Drug-Induced Liver Injury. Front Pharmacol 2021;12:723940. [PMID: 34721020 DOI: 10.3389/fphar.2021.723940] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
109 Chang HH, Chiang SY, Chen PC, Tsai CH, Yang RC, Tsai CL, Wu TH, Hsieh YW, Lin YC, Kuo YT, Chen KC, Chu HT. A system for reporting and evaluating adverse drug reactions of herbal medicine in Taiwan from 1998 to 2016. Sci Rep 2021;11:21476. [PMID: 34728662 DOI: 10.1038/s41598-021-00704-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
110 Barcelos STA, Dall'Oglio VM, de Araújo A, Cerski CTS, Álvares-da-Silva MR. Sinusoidal obstruction syndrome secondary the intake of Senecio brasiliensis: A case report. Ann Hepatol 2021;20:100138. [PMID: 31606353 DOI: 10.1016/j.aohep.2019.08.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
111 Ma J, Li M, Li N, Chan WY, Lin G. Pyrrolizidine Alkaloid-Induced Hepatotoxicity Associated with the Formation of Reactive Metabolite-Derived Pyrrole-Protein Adducts. Toxins (Basel) 2021;13:723. [PMID: 34679016 DOI: 10.3390/toxins13100723] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
112 Celsa C, Giuffrida P, Giacchetto CM, Stornello C, Rancatore G, Grova M, Ricciardi MR, Rizzo S, Cammà C, Cabibbo G. Hepatotoxicity of systemic therapies for unresectable hepatocellular carcinoma. Liver Cancer International 2021;2:82-95. [DOI: 10.1002/lci2.38] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
113 Delgado A, Stewart S, Urroz M, Rodríguez A, Borobia AM, Akatbach-Bousaid I, González-Muñoz M, Ramírez E. Characterisation of Drug-Induced Liver Injury in Patients with COVID-19 Detected by a Proactive Pharmacovigilance Program from Laboratory Signals. J Clin Med 2021;10:4432. [PMID: 34640458 DOI: 10.3390/jcm10194432] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
114 Teschke R, Vongdala N, Quan NV, Quy TN, Xuan TD. Metabolic Toxification of 1,2-Unsaturated Pyrrolizidine Alkaloids Causes Human Hepatic Sinusoidal Obstruction Syndrome: The Update. Int J Mol Sci 2021;22:10419. [PMID: 34638760 DOI: 10.3390/ijms221910419] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
115 Ortiz GX, Lenhart G, Becker MW, Schwambach KH, Tovo CV, Blatt CR. Drug-induced liver injury and COVID-19: A review for clinical practice. World J Hepatol 2021; 13(9): 1143-1153 [PMID: 34630881 DOI: 10.4254/wjh.v13.i9.1143] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
116 Teschke R, Danan G. The LiverTox Paradox-Gaps between Promised Data and Reality Check. Diagnostics (Basel) 2021;11:1754. [PMID: 34679453 DOI: 10.3390/diagnostics11101754] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
117 Li J, Zhang J, Xu X, Fang W, Qu S, Jin F, Zhou J, Han X, Raza HK, Li X, Mao Y. Hugan tablets for the treatment of RUCAM based drug-induced liver injury: a propensity score matching analysis using a nationwide database. Expert Rev Clin Pharmacol 2021;:1-8. [PMID: 34521298 DOI: 10.1080/17512433.2021.1981859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
118 Yao L, Nisar MF, Yan T, Wan C(, Cai S. Potential Effects of Dietary Isoflavones on Drug-Induced Liver Injury. Journal of Food Quality 2021;2021:1-10. [DOI: 10.1155/2021/2870969] [Reference Citation Analysis]
119 Lei X, Zhang J, Xu Q, Li J, Qian Y, Zhang J, Liu L, Zhong W, Wang Y, Han X, Tang J, Zeng M, Mao Y. Exploring the efficacy and safety of polyene phosphatidylcholine for treatment of drug-induced liver injury using the Roussel Uclaf causality assessment method: a propensity score matching comparison. J Int Med Res 2021;49:3000605211039810. [PMID: 34433332 DOI: 10.1177/03000605211039810] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
120 Nguyen PTT, Hoang DV, Pham KM, Nguyen HT. A Multiple Logistic Regression Model Based on Gamma-Glutamyl Transferase as a Biomarker for Early Prediction of Drug-Induced Liver Injury in Vietnamese Patients. J Clin Pharmacol 2022;62:110-7. [PMID: 34415063 DOI: 10.1002/jcph.1955] [Reference Citation Analysis]
121 Watanabe M, Shibuya A, Yokomori H, Koizumi W. The Diagnosis of Drug-induced Liver Injury: Current Diagnostic Ability and Future Challenges of the Digestive Disease Week-Japan 2004 Scale 15 Years after Its Proposal. Intern Med 2021;60:2557-68. [PMID: 33716281 DOI: 10.2169/internalmedicine.6370-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
122 Zhu L, Zhang C, Zhang W, Xia Q, Ma J, He X, He Y, Fu PP, Jia W, Zhuge Y, Lin G. Developing urinary pyrrole-amino acid adducts as non-invasive biomarkers for identifying pyrrolizidine alkaloids-induced liver injury in human. Arch Toxicol 2021. [PMID: 34390356 DOI: 10.1007/s00204-021-03129-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
123 Schmidt M. Kava – 20 Jahre Kampf gegen regulatorische Windmühlenflügel. Erfahrungsheilkunde 2021;70:199-203. [DOI: 10.1055/a-1528-4267] [Reference Citation Analysis]
124 Ho CM, Chen CL, Chang CH, Lee MR, Wang JY, Hu RH, Lee PH. Circulatory Inflammatory Mediators in the Prediction of Anti-Tuberculous Drug-Induced Liver Injury Using RUCAM for Causality Assessment. Biomedicines 2021;9:891. [PMID: 34440095 DOI: 10.3390/biomedicines9080891] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
125 Teschke R, Xuan TD. Suspected herb induced liver injury by green tea extracts: Critical review and case analysis applying RUCAM for causality assessment.Japanese J Gastroenterol Hepatol. 2019;6:1-16. [DOI: 10.21037/tgh-20-149] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
126 Suh Y, Ah YM, Chun HJ, Lee SM, Kim HS, Gu HJ, Kim AJ, Chung JE, Cho Y, Lee YH, Hwangbo SY, Kim J, Kim ES, Kim HB, Lee E, Lee JY. Potential Impact of the Involvement of Clinical Pharmacists in Antimicrobial Stewardship Programs on the Incidence of Antimicrobial-Related Adverse Events in Hospitalized Patients: A Multicenter Retrospective Study. Antibiotics (Basel) 2021;10:853. [PMID: 34356774 DOI: 10.3390/antibiotics10070853] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
127 Dinis-Oliveira RJ, Vieira DN. Acute liver failure requiring transplantation: A possible link to ulipristal acetate treatment? Basic Clin Pharmacol Toxicol 2021;129:278-82. [PMID: 34187080 DOI: 10.1111/bcpt.13631] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
128 Liu J, Dai XL, Zhou XJ, Gu BH, Yang ZH, Lai J. Metamizole-induced acute liver failure in a boy. Clin Res Hepatol Gastroenterol 2021;45:101570. [PMID: 33303406 DOI: 10.1016/j.clinre.2020.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
129 Mei X, Wu HC, Ruan M, Cai LR. Acute liver failure with thrombotic microangiopathy due to sodium valproate toxicity: A case report. World J Clin Cases 2021; 9(17): 4310-4317 [PMID: 34141795 DOI: 10.12998/wjcc.v9.i17.4310] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
130 Atallah E, Wijayasiri P, Cianci N, Abdullah K, Mukherjee A, Aithal GP. Zanubrutinib-induced liver injury: a case report and literature review. BMC Gastroenterol 2021;21:244. [PMID: 34051727 DOI: 10.1186/s12876-021-01825-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
131 Zhu J, Liu W, Zhang M, Lu L, Pan H, He X, Wang N, Yang M, Yi H, Tang S. A validation study of the UGT1A4 rs2011404 variant and the risk of anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population. J Clin Pharm Ther 2021. [PMID: 34046917 DOI: 10.1111/jcpt.13452] [Reference Citation Analysis]
132 Brar HS, Marathi R. Case of cholestatic drug-induced liver injury (DILI) associated with black cohosh. BMJ Case Rep 2021;14:e240408. [PMID: 33962922 DOI: 10.1136/bcr-2020-240408] [Reference Citation Analysis]
133 Masson W, Lobo M, Masson G, Molinero G, Casciato P. Statin use in patients with elevated serum hepatic transaminases at baseline: A meta-analysis. Nutr Metab Cardiovasc Dis 2021;31:1357-64. [PMID: 33715945 DOI: 10.1016/j.numecd.2021.01.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
134 Becker MW, Schwambach KH, Lunardelli M, Blatt CR. Overview of drug induced liver injury in Brazil: What is the role of public health policy on the evidence? World J Gastrointest Pharmacol Ther 2021; 12(3): 40-55 [PMID: 34046243 DOI: 10.4292/wjgpt.v12.i3.40] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
135 Zhao J, Blais JE, Seto WK, Wong ICK, Chan EW. Response to Liu et al., and Björnsson and Björnsson. Am J Gastroenterol 2021;116:1091-2. [PMID: 33229977 DOI: 10.14309/ajg.0000000000001055] [Reference Citation Analysis]
136 Wu H, Liu S, Luo H, Chen M. Progress in the Clinical Features and Pathogenesis of Abnormal Liver Enzymes in Coronavirus Disease 2019. J Clin Transl Hepatol 2021;9:239-46. [PMID: 34007806 DOI: 10.14218/JCTH.2020.00126] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
137 Han B, Yang Y, Tang L, Yang Q, Xie R. Roles of SET7/9 and LSD1 in the Pathogenesis of Arsenic-induced Hepatocyte Apoptosis. J Clin Transl Hepatol 2021;9:364-72. [PMID: 34221922 DOI: 10.14218/JCTH.2020.00185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
138 Raikhelson KL, Kondrashina EA, Pazenko EV. Mixed steatohepatitis: more questions than answers (part 2). Terapevticheskii arkhiv 2021;93:516-520. [DOI: 10.26442/00403660.2021.04.200755] [Reference Citation Analysis]
139 Xia C, Liu Y, Yao H, Zhu W, Ding J, Jin J. Causality assessment of skyfruit-induced liver injury using the updated RUCAM: a case report and review of the literature. J Int Med Res 2020;48:300060520917569. [PMID: 32293220 DOI: 10.1177/0300060520917569] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
140 Teschke R, Uetrecht J. Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues. Ann Transl Med 2021;9:730. [PMID: 33987428 DOI: 10.21037/atm-2020-ubih-05] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
141 Teschke R, Danan G. Idiosyncratic Drug Induced Liver Injury, Cytochrome P450, Metabolic Risk Factors and Lipophilicity: Highlights and Controversies. Int J Mol Sci 2021;22:3441. [PMID: 33810530 DOI: 10.3390/ijms22073441] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
142 Funakoshi H, Momo K, Kashima A, Ida H, Miyata Y, Sagara H, Sasaki T. Liver Injury by the Traditional Chinese Medicine Hanshirento, Zenshikunshito, and Ninjin'yoeito in a Patient with Lung Cancer: Probable Causality Assessed by the Updated Roussel Uclaf Causality Assessment Method. Integr Cancer Ther 2021;20:15347354211004734. [PMID: 33769124 DOI: 10.1177/15347354211004734] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
143 Hey-Hadavi J, Seekins D, Palmer M, Coffey D, Caminis J, Abdullaev S, Patwardhan M, Tyler H, Raheja R, Stanley AM, Pineda-Salgado L, Bourdet DL, Andrade RJ, Hayashi PH, Dimick-Santos L, Rockey DC, Estilo A. Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials. Drug Saf 2021;44:619-34. [PMID: 33725335 DOI: 10.1007/s40264-021-01051-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
144 Jee A, Sernoskie SC, Uetrecht J. Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges. Int J Mol Sci 2021;22:2954. [PMID: 33799477 DOI: 10.3390/ijms22062954] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
145 Karousatos CM, Lee JK, Braxton DR, Fong TL. Case series and review of Ayurvedic medication induced liver injury. BMC Complement Med Ther 2021;21:91. [PMID: 33714265 DOI: 10.1186/s12906-021-03251-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
146 Pai S, Njoku DB. The Role of Hypoxia-Induced Mitogenic Factor in Organ-Specific Inflammation in the Lung and Liver: Key Concepts and Gaps in Knowledge Regarding Molecular Mechanisms of Acute or Immune-Mediated Liver Injury. Int J Mol Sci 2021;22:2717. [PMID: 33800244 DOI: 10.3390/ijms22052717] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
147 Krovko YN, Shmigelskiy AV, Аkhmedov AD, Shulgina AA, Lukshin VA, Usachev DY. Enoxaparin-induced hepatotoxicity: clinical cases and literature review. Vestn anesteziol reanimatol 2021;18:84-92. [DOI: 10.21292/2078-5658-2021-18-1-84-92] [Reference Citation Analysis]
148 Teschke R, Danan G. Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM). Diagnostics (Basel) 2021;11:458. [PMID: 33800917 DOI: 10.3390/diagnostics11030458] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
149 Kanagalingam T, Lazarte J, Wong DKH, Hegele RA. Liver Injury Associated With Ezetimibe Monotherapy. CJC Open 2021;3:195-7. [PMID: 33644733 DOI: 10.1016/j.cjco.2020.09.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
150 Han Y, Zhuang Y, Tang W, Chen L, Chen Y, Gong Q, Zhang X. Congenital dyserythropoietic anemia and drug-induced liver injury present as bland cholestasis: A case report. Exp Ther Med 2021;21:456. [PMID: 33777192 DOI: 10.3892/etm.2021.9887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
151 Chen Y, Wang C, Yang H, Huang P, Shi J, Tong Y, Jiang J, Zhang X, Chen W, Xuan Z. Epidemiology of Drug- and Herb-Induced Liver Injury Assessed for Causality Using the Updated RUCAM in Two Hospitals from China. Biomed Res Int 2021;2021:8894498. [PMID: 33954202 DOI: 10.1155/2021/8894498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
152 Pedraza L, Laosa O, Rodríguez-Mañas L, Gutiérrez-Romero DF, Frías J, Carnicero JA, Ramírez E. Drug Induced Liver Injury in Geriatric Patients Detected by a Two-Hospital Prospective Pharmacovigilance Program: A Comprehensive Analysis Using the Roussel Uclaf Causality Assessment Method. Front Pharmacol 2020;11:600255. [PMID: 33613279 DOI: 10.3389/fphar.2020.600255] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
153 Shao YM, Zhang Y, Yin X, Qin TT, Jin QL, Wen XY. Herb-induced autoimmune-like hepatitis associated with Xiang-tian-guo (Swietenia macrophylla seeds): A case report and literature review. Medicine (Baltimore) 2021;100:e24045. [PMID: 33466156 DOI: 10.1097/MD.0000000000024045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
154 Yamamoto T, Ishigami K, Ueno A, Akutsu N, Numata Y, Wagatsuma K, Sasaki S, Nakase H. Sustained hyperbilirubinemia following clarithromycin administration. Medicine: Case Reports and Study Protocols 2021;2:e0057. [DOI: 10.1097/md9.0000000000000057] [Reference Citation Analysis]
155 Compaoré YD, Zongo I, Somé AF, Barry N, Nikiéma F, Kaboré TN, Ouattara A, Kabré Z, Wermi K, Zongo M, Yerbanga RS, Sagara I, Djimdé A, Ouédraogo JB. Hepatic safety of repeated treatment with pyronaridine-artesunate versus artemether-lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso. Malar J 2021;20:64. [PMID: 33514368 DOI: 10.1186/s12936-021-03593-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
156 Maor Y, Ergaz D, Malnick SDH, Melzer E, Neuman MG. Liraglutide-Induced Hepatotoxicity. Biomedicines 2021;9:106. [PMID: 33498980 DOI: 10.3390/biomedicines9020106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
157 Patel R, Alavi F, Ortega S, Matela A. Herb-Induced Liver Injury by Cimicifuga racemosa and Thuja occidentalis Herbal Medications for Fertility. Case Rep Gastrointest Med 2021;2021:8858310. [PMID: 33532101 DOI: 10.1155/2021/8858310] [Reference Citation Analysis]
158 Ostrovsky V, Malnick S, Ish-Shalom S, Ziv Sokolowskaia N, Yosepovich A, Neuman M. Denosumab-Induced Immune Hepatitis. Biomedicines 2021;9:76. [PMID: 33466886 DOI: 10.3390/biomedicines9010076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
159 Vidal-Cevallos P, Higuera-De-La-Tijera F, Chávez-Tapia NC, Sanchez-Giron F, Cerda-Reyes E, Rosales-Salyano VH, Servin-Caamaño A, Vázquez-Medina MU, Méndez-Sánchez N. Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study. Ann Hepatol 2021;24:100338. [PMID: 33647501 DOI: 10.1016/j.aohep.2021.100338] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
160 Abbass A, Khalid S, Farooq U, Rakov N, Hanson J, Martin D, McCarthy D. If DILI Is Suspected, Don't Dally. Dig Dis Sci 2021;66:52-5. [PMID: 33398719 DOI: 10.1007/s10620-020-06730-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
161 Chen F, Chen W, Chen J, Xu D, Xie W, Wang X, Xie Y. Clinical features and risk factors of COVID-19-associated liver injury and function: A retrospective analysis of 830 cases. Ann Hepatol 2021;21:100267. [PMID: 33053426 DOI: 10.1016/j.aohep.2020.09.011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
162 Nagral A, Adhyaru K, Rudra OS, Gharat A, Bhandare S. Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series. J Clin Exp Hepatol 2021;11:732-8. [PMID: 34230786 DOI: 10.1016/j.jceh.2021.06.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]
163 Praharaj DL, Mallick B, Nath P, Panigrahi SC, Padhan P, Sahu N. Unusual Presentation of Systemic Lupus Erythematosus in a Young Male: A Case Report. J Clin Exp Hepatol 2021;11:264-9. [PMID: 33746453 DOI: 10.1016/j.jceh.2020.05.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
164 Saravanapriya P, Devi KP. Plant extracts with putative hepatotoxicity activity. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases 2021. [DOI: 10.1016/b978-0-12-816488-4.00002-4] [Reference Citation Analysis]
165 Park HJ, Seo KI, Choi YI. Liver transplantation for azithromycin-induced severe liver injury. Korean Journal of Transplantation 2020;34:279-285. [DOI: 10.4285/kjt.20.0017] [Reference Citation Analysis]
166 Yamazaki S, Suzuki T, Sayama M, Nakada TA, Igari H, Ishii I. Suspected cholestatic liver injury induced by favipiravir in a patient with COVID-19. J Infect Chemother 2021;27:390-2. [PMID: 33402301 DOI: 10.1016/j.jiac.2020.12.021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
167 Ferreira I, Gouveia C, Vasques C Sr, Faria C, Pedroso A. Drug-Induced Liver Injury Caused by Amoxicillin/Clavulanate. Cureus 2020;12:e12234. [PMID: 33500857 DOI: 10.7759/cureus.12234] [Reference Citation Analysis]
168 Smok AM, Malkova AM, Kudlay DA, Starshinova AA. Possibilities for correcting hepatotoxic reactions during therapy in patients with COVID-19 (case report). Transl med (Print) 2020;7:65-72. [DOI: 10.18705/2311-4495-2020-7-6-65-72] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
169 Baraniak J, Kania-dobrowolska M. Pelargonium root ( Pelargonium sidoides DC) extract in paediatric patients - food supplement or medicine? Herba Polonica 2020;66:28-33. [DOI: 10.2478/hepo-2020-0009] [Reference Citation Analysis]
170 Yang M, Qiu Y, Jin Y, Liu W, Wang Q, Yi H, Tang S. NR1I2 genetic polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity: A systematic review and meta-analysis. Pharmacol Res Perspect 2020;8:e00696. [PMID: 33300686 DOI: 10.1002/prp2.696] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
171 Umbaugh DS, Jaeschke H. Biomarkers of drug-induced liver injury: a mechanistic perspective through acetaminophen hepatotoxicity. Expert Rev Gastroenterol Hepatol 2021;15:363-75. [PMID: 33242385 DOI: 10.1080/17474124.2021.1857238] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
172 Lee SH, Kim SY, Yang SB, Jin C, Kwon S, Cho SY, Park SU, Jung WS, Moon SK, Park JM, Ko CN. Safety of co-administration of herbal and conventional medicines on liver and kidney function in stroke patients: A single-center retrospective study. Phytomedicine 2021;81:153435. [PMID: 33338904 DOI: 10.1016/j.phymed.2020.153435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
173 López-Riera M, Conde I, Castell JV, Jover R. A Novel MicroRNA Signature for Cholestatic Drugs in Human Hepatocytes and Its Translation into Novel Circulating Biomarkers for Drug-Induced Liver Injury Patients. Toxicol Sci 2020;173:229-43. [PMID: 31198949 DOI: 10.1093/toxsci/kfz138] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
174 González-Muñoz M, Monserrat Villatoro J, Marín-Serrano E, Stewart S, Bardón Rivera B, Marín J, Martínez de Soto L, Seco Meseguer E, Ramírez E. A case report of a drug-induced liver injury (DILI) caused by multiple antidepressants with causality established by the updated Roussel Uclaf causality assessment method (RUCAM) and in vitro testing. Clin Case Rep 2020;8:3105-9. [PMID: 33363890 DOI: 10.1002/ccr3.3348] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
175 Kesenogile B, Godman B, Rwegerera GM. Alanine transaminase and hemoglobin appear to predict the occurrence of antituberculosis medication hepatotoxicity; findings and implications in Botswana. Expert Rev Anti Infect Ther 2021;19:379-91. [PMID: 32909487 DOI: 10.1080/14787210.2020.1822735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
176 O'Reilly M, Mellotte G, Ryan B, O'Connor A. Gastrointestinal side effects of cancer treatments. Ther Adv Chronic Dis 2020;11:2040622320970354. [PMID: 33294145 DOI: 10.1177/2040622320970354] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
177 Li D, Yang M, Zuo Z. Overview of Pharmacokinetics and Liver Toxicities of Radix Polygoni Multiflori.Toxins (Basel). 2020;12. [PMID: 33233441 DOI: 10.3390/toxins12110729] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
178 Sriapha C, Trakulsrichai S, Tongpoo A, Pradoo A, Rittilert P, Wananukul W. Acute Imidacloprid Poisoning in Thailand. Ther Clin Risk Manag 2020;16:1081-8. [PMID: 33204096 DOI: 10.2147/TCRM.S269161] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
179 Kuchta K, Hladikova M, Thomsen M, Nahrstedt A, Schmidt M. Kava (Piper methysticum) Extract for the Treatment of Nervous Anxiety, Tension and Restlessness. Drug Res (Stuttg) 2021;71:83-93. [PMID: 33207379 DOI: 10.1055/a-1268-7135] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
180 Abeles RD, Foxton M, Khan S, Goldin R, Smith B, Thursz MR, Verma S. Androgenic anabolic steroid-induced liver injury: two case reports assessed for causality by the updated Roussel Uclaf Causality Assessment Method (RUCAM) score and a comprehensive review of the literature. BMJ Open Gastroenterol 2020;7:e000549. [PMID: 33214235 DOI: 10.1136/bmjgast-2020-000549] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
181 Thomsen M, Schmidt M. Health policy versus kava (Piper methysticum): Anxiolytic efficacy may be instrumental in restoring the reputation of a major South Pacific crop. J Ethnopharmacol 2021;268:113582. [PMID: 33189846 DOI: 10.1016/j.jep.2020.113582] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
182 Hiraki M, Tanaka T, Koga F, Saito A, Oza N, Ikeda O, Manabe T, Miyoshi A, Kitahara K, Sato S, Noshiro H. An Unusual Case of Acute Liver Failure Caused by Adjuvant Oral Tegafur-Uracil with Folinate Therapy for Colon Cancer Patient: a Case Report. J Gastrointest Cancer 2020;51:296-9. [PMID: 30903577 DOI: 10.1007/s12029-019-00228-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
183 Singh AK, Verma S, Kumar-M P, Soni H, Sharma S, Patil A, Sharma V. Appropriate chemopreventive strategy for anti-tubercular therapy related liver injury is unsettled: Results from a systematic review and network meta-analysis.Expert Rev Clin Pharmacol. 2020;13:1253-1262. [PMID: 33043729 DOI: 10.1080/17512433.2020.1835468] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
184 Mascherona I, Maggioli C, Biggiogero M, Mora O, Marelli L. A Severe Case of Drug-Induced Liver Injury after Gemcitabine Administration: A Highly Probable Causality Grading as Assessed by the Updated RUCAM Diagnostic Scoring System. Case Reports Hepatol 2020;2020:8812983. [PMID: 33083070 DOI: 10.1155/2020/8812983] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
185 Ivashkin VT, Raikhelson KL, Palgova LK, Maevskaya MV, Gerasimova OA, Kondrashina EA, Marchenko NV, Baranovsky AY. Drug-induced liver injury in cancer patients. Onkogematologiâ 2020;15:80-94. [DOI: 10.17650/1818-8346-2020-15-3-80-94] [Reference Citation Analysis]
186 Schimmel J, Dart RC. Kratom (Mitragyna Speciosa) Liver Injury: A Comprehensive Review.Drugs. 2020;80:263-283. [PMID: 31919755 DOI: 10.1007/s40265-019-01242-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
187 Teschke R, Danan G. Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive Analysis. Medicines (Basel) 2020;7:E62. [PMID: 33003400 DOI: 10.3390/medicines7100062] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 11.7] [Reference Citation Analysis]
188 Hayashi M, Abe K, Fujita M, Takahashi A, Kobayashi Y, Hashimoto Y, Ohira H. Pazopanib-induced mixed liver injury in a patient with soft-tissue sarcoma, but without the UGT1A1*28 mutation: a case report. Clin J Gastroenterol 2021;14:224-8. [PMID: 32990937 DOI: 10.1007/s12328-020-01253-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
189 Danjuma MI, Almasri H, Alshokri S, Khir FK, Elmalik A, Battikh NG, Abdallah IMH, Elshafei M, Fatima H, Mohamed MFH, Maghoub Y, Hussain T, Kamal I, Anwer Z, Bidmos MA, Elzouki AN. Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score. BMC Geriatr 2020;20:346. [PMID: 32928134 DOI: 10.1186/s12877-020-01732-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
190 Ferron PJ, Gicquel T, Mégarbane B, Clément B, Fromenty B. Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury? Biochimie 2020;179:266-74. [PMID: 32891697 DOI: 10.1016/j.biochi.2020.08.018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
191 Garcia-Cortes M, Robles-Diaz M, Stephens C, Ortega-Alonso A, Lucena MI, Andrade RJ. Drug induced liver injury: an update.Arch Toxicol. 2020;94:3381-3407. [PMID: 32852569 DOI: 10.1007/s00204-020-02885-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 18.0] [Reference Citation Analysis]
192 Ahmadi AR, Chicco M, van den Berge M. Rifampicin for Treatment of Cholestatic Pruritus Caused by Drug-Induced Acute Liver Injury as Assessed by the RUCAM Classification. Case Reports Hepatol 2020;2020:8872804. [PMID: 32832174 DOI: 10.1155/2020/8872804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
193 Lombardi N, Crescioli G, Maggini V, Ippoliti I, Menniti-Ippolito F, Gallo E, Brilli V, Lanzi C, Mannaioni G, Firenzuoli F, Vannacci A. Acute liver injury following turmeric use in Tuscany: An analysis of the Italian Phytovigilance database and systematic review of case reports. Br J Clin Pharmacol 2021;87:741-53. [PMID: 32656820 DOI: 10.1111/bcp.14460] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 4.7] [Reference Citation Analysis]
194 Quan NV, Dang Xuan T, Teschke R. Potential Hepatotoxins Found in Herbal Medicinal Products: A Systematic Review. Int J Mol Sci 2020;21:E5011. [PMID: 32708570 DOI: 10.3390/ijms21145011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
195 Kang S, Brinker A, Jones SC, Dimick-santos L, Avigan MI. An Evaluation of Postmarketing Reports of Serious Idiosyncratic Liver Injury Associated with Ulipristal Acetate for the Treatment of Uterine Fibroids. Drug Saf 2020;43:1267-76. [DOI: 10.1007/s40264-020-00960-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
196 Peeraphatdit TB, Wang J, Odenwald MA, Hu S, Hart J, Charlton MR. Hepatotoxicity From Immune Checkpoint Inhibitors: A Systematic Review and Management Recommendation. Hepatology 2020;72:315-29. [PMID: 32167613 DOI: 10.1002/hep.31227] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 27.3] [Reference Citation Analysis]
197 Mehershahi S, Mantri N, Kumar A, Danial S, Harish P. Enoxaparin-Induced Liver Injury. Case Rep Gastroenterol 2020;14:315-9. [PMID: 32595436 DOI: 10.1159/000508471] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
198 Yang L, Shou Y, Li F, Zhu X, Yang Y, Xu J. Retrospective study of 213 cases of Stevens–Johnson syndrome and toxic epidermal necrolysis from China. Burns 2020;46:959-69. [DOI: 10.1016/j.burns.2019.10.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
199 Adiga U, Adiga S, Banawalikar N, Shenoy V. Influence Of UGT1A3 Gene Polymorphism In Pediatric Epileptics on Valproate: A Protocol (Preprint).. [DOI: 10.2196/preprints.20878] [Reference Citation Analysis]
200 Bezvulyak EI, Basharin VA, Epifantsev AV, Kutsenko VP, Seliverstov PV. Prevention options of toxic drug-induced liver disease in patients with chemotherapy of oncological diseases. Medicinskij sovet 2020. [DOI: 10.21518/2079-701x-2020-5-42-49] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
201 Yu Y, Nie X, Song Z, Xie Y, Zhang X, Du Z, Wei R, Fan D, Liu Y, Zhao Q, Peng X, Jia L, Wang X. Signal Detection of Potentially Drug-Induced Liver Injury in Children Using Electronic Health Records. Front Pediatr 2020;8:171. [PMID: 32373564 DOI: 10.3389/fped.2020.00171] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
202 Teschke R, Zhu Y, Jing J. Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases. J Clin Transl Hepatol 2020;8:200-14. [PMID: 32832401 DOI: 10.14218/JCTH.2020.00009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
203 Tao B, Yang M, Chen H, Pan H, Liu W, Yi H, Tang S. Association of ABO blood group and antituberculosis drug-induced liver injury: A case-control study from a Chinese Han population. J Clin Pharm Ther 2020;45:638-45. [PMID: 32259340 DOI: 10.1111/jcpt.13139] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
204 Larrey D. Actualité dans l’hépatotoxicité des médicaments et autres xénobiotiques. Le rôle des compléments alimentaires. Hegel 2020;N° 2:107-117. [DOI: 10.3917/heg.102.0107] [Reference Citation Analysis]
205 Sandhu N, Navarro V. Drug-Induced Liver Injury in GI Practice. Hepatol Commun. 2020;4:631-645. [PMID: 32363315 DOI: 10.1002/hep4.1503] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
206 Kulkarni AV, Kumar P, Talukdar R, Rao NP. Steroids as rescue therapy for vitamin A-induced acute liver failure. BMJ Case Rep 2020;13:e233902. [PMID: 32139453 DOI: 10.1136/bcr-2019-233902] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
207 Avila C, Breakspear I, Hawrelak J, Salmond S, Evans S. A systematic review and quality assessment of case reports of adverse events for borage (Borago officinalis), coltsfoot (Tussilago farfara) and comfrey (Symphytum officinale). Fitoterapia 2020;142:104519. [PMID: 32105669 DOI: 10.1016/j.fitote.2020.104519] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
208 Jakabovičová M, Ďurkovičová Z, Hlavatá T, Szántová M. Hepatotoxicity induced by bodybuilding supplements. Vnitr Lek 2020;66:28-33. [DOI: 10.36290/vnl.2020.005] [Reference Citation Analysis]
209 Oketch-Rabah HA, Roe AL, Rider CV, Bonkovsky HL, Giancaspro GI, Navarro V, Paine MF, Betz JM, Marles RJ, Casper S, Gurley B, Jordan SA, He K, Kapoor MP, Rao TP, Sherker AH, Fontana RJ, Rossi S, Vuppalanchi R, Seeff LB, Stolz A, Ahmad J, Koh C, Serrano J, Low Dog T, Ko R. United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts. Toxicol Rep 2020;7:386-402. [PMID: 32140423 DOI: 10.1016/j.toxrep.2020.02.008] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 21.0] [Reference Citation Analysis]
210 Shrestha S, Danekhu K, Sapkota B, Jha N, Kc B. Herbal pharmacovigilance in Nepal: challenges and recommendations. F1000Res 2020;9:111. [DOI: 10.12688/f1000research.22133.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
211 Chayanupatkul M, Schiano TD. Acute Liver Failure Secondary to Drug-Induced Liver Injury. Clin Liver Dis 2020;24:75-87. [PMID: 31753252 DOI: 10.1016/j.cld.2019.09.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
212 Real M, Barnhill MS, Higley C, Rosenberg J, Lewis JH. Drug-Induced Liver Injury: Highlights of the Recent Literature. Drug Saf 2019;42:365-87. [PMID: 30343418 DOI: 10.1007/s40264-018-0743-2] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 18.0] [Reference Citation Analysis]
213 Chow HC, So TH, Choi HCW, Lam KO. Literature Review of Traditional Chinese Medicine Herbs-Induced Liver Injury From an Oncological Perspective With RUCAM. Integr Cancer Ther 2019;18:1534735419869479. [PMID: 31405304 DOI: 10.1177/1534735419869479] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
214 Wang L, Zheng C, Zhao D. Successful management of germanium poisoning-induced multiple organ dysfunctions by combined blood purification therapy. Curr Med Res Opin 2020;36:687-91. [PMID: 31951756 DOI: 10.1080/03007995.2020.1717452] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
215 Colaci CS, Mendizabal M, Bessone F. Idiosyncratic Drug-Induced Acute Liver Failure: A Challenging and Distressing Scenario. Curr Drug Saf 2019;14:94-101. [PMID: 30767751 DOI: 10.2174/1574886314666190215115434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
216 Teschke R, Danan G. Drug Induced Liver Injury: Mechanisms, Diagnosis, and Clinical Management. Liver Diseases 2020. [DOI: 10.1007/978-3-030-24432-3_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
217 Teschke R. Acetaminophen syn. Paracetamol: Acute Liver Injury and Acute on Chronic Liver Failure with Case Analysis and Causality Assessment Using RUCAM. Liver Failure 2020. [DOI: 10.1007/978-3-030-50983-5_12] [Reference Citation Analysis]
218 Hatami B, Saffaei A, Jamali F, Abbasinazari M. Glutamine powder-induced hepatotoxicity: it is time to understand the side effects of sports nutritional supplements. Gastroenterol Hepatol Bed Bench 2020;13:86-9. [PMID: 32190229] [Reference Citation Analysis]
219 Seo H, Seo H, Shim S, Lee C, Cho I, Han C, Kim, S, Choi J, Park S, Yun Y, Hong J, Kwon J, Lee I. Effect of Herbal Medicine on Liver Function in Korean Medical Hospital Inpatients: A Retrospective Chart Review. J Int Korean Med 2019;40:1145-1151. [DOI: 10.22246/jikm.2019.40.6.1145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
220 Teschke R, Eickhoff A, Brown AC, Neuman MG, Schulze J. Diagnostic Biomarkers in Liver Injury by Drugs, Herbs, and Alcohol: Tricky Dilemma after EMA Correctly and Officially Retracted Letter of Support. Int J Mol Sci 2019;21:E212. [PMID: 31892250 DOI: 10.3390/ijms21010212] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
221 Antony A, Lee TP. Herb-Induced Liver Injury With Cholestasis and Renal Injury Secondary to Short-Term Use of Kratom (Mitragyna speciosa). Am J Ther 2019;26:e546-7. [PMID: 29927773 DOI: 10.1097/MJT.0000000000000802] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
222 Savage RL, Hill GR, Barnes J, Kenyon SH, Tatley MV. Suspected Hepatotoxicity With a Supercritical Carbon Dioxide Extract of Artemisia annua in Grapeseed Oil Used in New Zealand. Front Pharmacol 2019;10:1448. [PMID: 31920644 DOI: 10.3389/fphar.2019.01448] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
223 Zeng B, Yuan L, Chu J, Yang Y, Lin S. Challenges in early identification of causes and treatment of cholestasis in patients with hyperthyroidism: a case report and literature review. J Int Med Res 2020;48:300060519891018. [PMID: 31840543 DOI: 10.1177/0300060519891018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
224 Liu Y, Wang W, Sun M, Ma B, Pang L, Du Y, Dong X, Yin X, Ni J. Polygonum multiflorum-Induced Liver Injury: Clinical Characteristics, Risk Factors, Material Basis, Action Mechanism and Current Challenges. Front Pharmacol 2019;10:1467. [PMID: 31920657 DOI: 10.3389/fphar.2019.01467] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
225 Meunier L, Larrey D. Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation. Front Pharmacol 2019;10:1482. [PMID: 31920666 DOI: 10.3389/fphar.2019.01482] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 8.3] [Reference Citation Analysis]
226 Sarris J, Byrne GJ, Bousman CA, Cribb L, Savage KM, Holmes O, Murphy J, Macdonald P, Short A, Nazareth S, Jennings E, Thomas SR, Ogden E, Chamoli S, Scholey A, Stough C. Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study. Aust N Z J Psychiatry 2020;54:288-97. [PMID: 31813230 DOI: 10.1177/0004867419891246] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
227 González-vázquez MD, Rafael-marques MS, Marques-de Sousa S, Duarte MA, Coelho ÂD. No existen fármacos inocentes: daño hepatocelular inducido por desloratadina. reccmi 2019;4:111-114. [DOI: 10.32818/reccmi.a4n3a4] [Reference Citation Analysis]
228 Mullins C, Beaulac K, Sylvia L. Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment. Ann Pharmacother 2020;54:526-32. [PMID: 31786964 DOI: 10.1177/1060028019892587] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
229 Ben-nasr H, Ksouda K, Harrabi B, Hammami ST, Zeghal K, Affes H. Pediatric liver failure following mefenamic acid associated to herbal auto-medication: A case report. Therapies 2019;74:677-680. [DOI: 10.1016/j.therap.2019.04.001] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
230 Yousaf MN, Chaudhary FS, Hodanazari SM, Sittambalam CD. Hepatotoxicity associated with Garcinia cambogia: A case report. World J Hepatol 2019;11:735-42. [PMID: 31772720 DOI: 10.4254/wjh.v11.i11.735] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
231 Xie C, Abdullah HMA, Abdallah M, Quist E, Niazi M. Anastrozole-induced liver injury after a prolonged latency: a very rare complication of a commonly prescribed medication. BMJ Case Rep 2019;12:e231741. [PMID: 31780604 DOI: 10.1136/bcr-2019-231741] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
232 Yan Y, Wang K, Tang X, Gao JF, Wen BY. Phytochemicals protect L02 cells against hepatotoxicity induced by emodin via the Nrf2 signaling pathway. Toxicol Res (Camb) 2019;8:1028-34. [PMID: 32153769 DOI: 10.1039/c9tx00220k] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
233 Steele L, Cummin A, Keohane SG. Acute cutaneous toxicity with kava: an inflammatory sebotropic reaction and urticaria. Clin Exp Dermatol 2020;45:527-30. [PMID: 31709587 DOI: 10.1111/ced.14129] [Reference Citation Analysis]
234 van Hunsel F, van de Koppel S, Skalli S, Kuemmerle A, Teng L, Wang JB, Barnes J. Analysis of Hepatobiliary Disorder Reports Associated With the Use of Herbal Medicines in the Global Suspected ADR Database Vigibase. Front Pharmacol 2019;10:1326. [PMID: 31780942 DOI: 10.3389/fphar.2019.01326] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
235 Yang M, Li Z, Dou D. Can Retrospective Studies Confirm Causes of Drug-Induced Liver Injury? Gastroenterology 2019;157:1436-7. [PMID: 31442432 DOI: 10.1053/j.gastro.2019.03.078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
236 Imam Z, Khasawneh M, Jomaa D, Iftikhar H, Sayedahmad Z. Drug Induced Liver Injury Attributed to a Curcumin Supplement. Case Rep Gastrointest Med. 2019;2019:6029403. [PMID: 31781418 DOI: 10.1155/2019/6029403] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
237 Liu R, Li X, Huang N, Fan M, Sun R. Toxicity of traditional Chinese medicine herbal and mineral products. Adv Pharmacol 2020;87:301-46. [PMID: 32089237 DOI: 10.1016/bs.apha.2019.08.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
238 Ruperti-Repilado FJ, Haefliger S, Rehm S, Zweier M, Rentsch KM, Blum J, Jetter A, Heim M, Leuppi-Taegtmeyer A, Terracciano L, Bernsmeier C. Danger of Herbal Tea: A Case of Acute Cholestatic Hepatitis Due to Artemisia annua Tea. Front Med (Lausanne) 2019;6:221. [PMID: 31681778 DOI: 10.3389/fmed.2019.00221] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
239 Weber S, Benesic A, Rotter I, Gerbes AL. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis. Liver Int 2019;39:1906-17. [PMID: 31319011 DOI: 10.1111/liv.14195] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
240 Grievink HW, Heuberger JAAC, Huang F, Chaudhary R, Birkhoff WAJ, Tonn GR, Mosesova S, Erickson R, Moerland M, Haddick PCG, Scearce-Levie K, Ho C, Groeneveld GJ. DNL104, a Centrally Penetrant RIPK1 Inhibitor, Inhibits RIP1 Kinase Phosphorylation in a Randomized Phase I Ascending Dose Study in Healthy Volunteers. Clin Pharmacol Ther 2020;107:406-14. [PMID: 31437302 DOI: 10.1002/cpt.1615] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
241 Grudzinski IP, Ruzycka M, Cieszanowski A, Szeszkowski W, Badurek I, Malkowska A, Bamburowicz-Klimkowska M. MRI-based preclinical discovery of DILI: A lesson from paracetamol-induced hepatotoxicity. Regul Toxicol Pharmacol 2019;108:104478. [PMID: 31539568 DOI: 10.1016/j.yrtph.2019.104478] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
242 Ma S, Liu S, Wang Q, Chen L, Yang P, Sun H. Fenofibrate-induced hepatotoxicity: A case with a special feature that is different from those in the LiverTox database. J Clin Pharm Ther 2020;45:204-7. [PMID: 31518450 DOI: 10.1111/jcpt.13042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
243 Alqrinawi SH, Akbar N, AlFaddag H, Akbar S, Akbar L, Butt SA, Aljawad M. Menotrophin Induced Autoimmune Hepatitis. Case Rep Gastrointest Med 2019;2019:7343805. [PMID: 31565446 DOI: 10.1155/2019/7343805] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
244 Peng Y, Wu Z, Yang H, Cai Y, Liu G, Li W, Tang Y. Insights into mechanisms and severity of drug-induced liver injury via computational systems toxicology approach. Toxicology Letters 2019;312:22-33. [DOI: 10.1016/j.toxlet.2019.05.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
245 Liu Z, He X, Wang L, Zhang Y, Hai Y, Gao R. Chinese Herbal Medicine Hepatotoxicity: The Evaluation and Recognization Based on Large-scale Evidence Database. Curr Drug Metab 2019;20:138-46. [PMID: 30101702 DOI: 10.2174/1389200219666180813144114] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
246 Shumar J, Ordway S, Junga Z, Sadowski B, Torres D. Memantine-Induced Liver Injury With Probable Causality as Assessed Using the Roussel Uclaf Causality Assessment Method (RUCAM). ACG Case Rep J 2019;6:e00184. [PMID: 31737715 DOI: 10.14309/crj.0000000000000184] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
247 Andrade RJ, Chalasani N, Björnsson ES, Suzuki A, Kullak-Ublick GA, Watkins PB, Devarbhavi H, Merz M, Lucena MI, Kaplowitz N, Aithal GP. Drug-induced liver injury. Nat Rev Dis Primers 2019;5:58. [PMID: 31439850 DOI: 10.1038/s41572-019-0105-0] [Cited by in Crossref: 215] [Cited by in F6Publishing: 229] [Article Influence: 53.8] [Reference Citation Analysis]
248 Danan G, Teschke R. Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future. Front Pharmacol. 2019;10:853. [PMID: 31417407 DOI: 10.3389/fphar.2019.00853] [Cited by in Crossref: 47] [Cited by in F6Publishing: 52] [Article Influence: 11.8] [Reference Citation Analysis]
249 Riebensahm C, Ka D, Sow A, Semmo N, Wandeler G. A closer look at the spectrum of drug-induced liver injury in sub-Saharan Africa. Expert Rev Clin Pharmacol 2019;12:875-83. [PMID: 31269818 DOI: 10.1080/17512433.2019.1638251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
250 Teschke R. Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019. Front Pharmacol 2019;10:730. [PMID: 31396080 DOI: 10.3389/fphar.2019.00730] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 9.0] [Reference Citation Analysis]
251 Yang H, Guo D, Xu Y, Zhu M, Yao C, Chen C, Jia W. Comparison of Different Liver Test Thresholds for Drug-Induced Liver Injury: Updated RUCAM versus Other Methods. Front Pharmacol 2019;10:816. [PMID: 31379581 DOI: 10.3389/fphar.2019.00816] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
252 He X, Wu Z, Wang L, Gao X, Hai Y, Liu W, Du L, Zhang L, Yang A, Huang N. An important mechanism of herb-induced hepatotoxicity: To produce RMs based on active functional groups-containing ingredients from phytomedicine by binding CYP450s. Chinese Herbal Medicines 2019;11:239-57. [DOI: 10.1016/j.chmed.2019.07.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
253 Pholmoo N, Bunchorntavakul C. Characteristics and Outcomes of Acetaminophen Overdose and Hepatotoxicity in Thailand. J Clin Transl Hepatol 2019;7:132-9. [PMID: 31293913 DOI: 10.14218/JCTH.2018.00066] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
254 H Alqrinawi S, Akbar N, Faddag HA, Akbar S, Akbar L, A S, Aljawad M. Menotrophin induced autoimmune hepatitis: a case report. GHOA 2019;10:164-166. [DOI: 10.15406/ghoa.2019.10.00376] [Reference Citation Analysis]
255 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, Clinical Practice Guideline Panel: Chair:, Panel members, EASL Governing Board representative:. EASL Clinical Practice Guidelines: Drug-induced liver injury. J Hepatol 2019;70:1222-61. [PMID: 30926241 DOI: 10.1016/j.jhep.2019.02.014] [Cited by in Crossref: 396] [Cited by in F6Publishing: 395] [Article Influence: 99.0] [Reference Citation Analysis]
256 Zhang F, Zhou Y, Yang X, Xiong AZ, Wang ZT, Yang L. Gynura Rhizoma containing pyrrolizidine alkaloids induces the hepatic sinusoidal obstruction syndrome in mice via upregulating fibrosis-related factors. Acta Pharmacol Sin 2019;40:781-9. [PMID: 30367152 DOI: 10.1038/s41401-018-0155-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
257 Nhean S, Yoong D, Wong DK, Gough K, Tseng AL. Probable hepatotoxicity with dolutegravir: report of two cases and review of the literature. AIDS 2019;33:1261-3. [PMID: 31045944 DOI: 10.1097/QAD.0000000000002191] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
258 Cope RB. Toxicology and Drug Interactions of Nutraceuticals. In: Gupta RC, Srivastava A, Lall R, editors. Nutraceuticals in Veterinary Medicine. Cham: Springer International Publishing; 2019. pp. 711-27. [DOI: 10.1007/978-3-030-04624-8_51] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
259 Lu L, Tao B, Wei H, Chen H, He X, Pan H, Yang M, Yi H, Tang S. Relevance of NAT2 genotype to anti-tuberculosis drug-induced hepatotoxicity in a Chinese Han population. J Gene Med 2019;21:e3096. [PMID: 31066138 DOI: 10.1002/jgm.3096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
260 Ma J, Ruan J, Chen X, Li D, Yao S, Fu PP, Ye Y, Gao H, Wang J, Lin G. Pyrrole-Hemoglobin Adducts, a More Feasible Potential Biomarker of Pyrrolizidine Alkaloid Exposure. Chem Res Toxicol 2019;32:1027-39. [PMID: 31012303 DOI: 10.1021/acs.chemrestox.8b00369] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
261 Wu Q, Cai C, Guo P, Chen M, Wu X, Zhou J, Luo Y, Zou Y, Liu AL, Wang Q, Kuang Z, Fang J. In silico Identification and Mechanism Exploration of Hepatotoxic Ingredients in Traditional Chinese Medicine. Front Pharmacol 2019;10:458. [PMID: 31130860 DOI: 10.3389/fphar.2019.00458] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
262 Lee MS, Lee JY, Kang MG, Jung JW, Park HK, Park HK, Kim SH, Lee EK. Cost implications of adverse drug event-related emergency department visits - a multicenter study in South Korea. Expert Rev Pharmacoecon Outcomes Res 2020;20:139-46. [PMID: 31012333 DOI: 10.1080/14737167.2019.1608825] [Reference Citation Analysis]
263 Tillmann HL, Suzuki A, Barnhart HX, Serrano J, Rockey DC. Tools for causality assessment in drug-induced liver disease. Curr Opin Gastroenterol 2019;35:183-90. [PMID: 30865042 DOI: 10.1097/MOG.0000000000000526] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
264 Xiao X, Tang J, Mao Y, Li X, Wang J, Liu C, Sun K, Ye Y, Zou Z, Peng C, Yang L, Guo Y, Bai Z, He T, Jing J, Li F, An N. Guidance for the clinical evaluation of traditional Chinese medicine-induced liver injuryIssued by China Food and Drug Administration. Acta Pharm Sin B 2019;9:648-58. [PMID: 31193760 DOI: 10.1016/j.apsb.2018.12.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
265 Watkins PB. Idiosyncratic drug-induced liver injury in patients: Detection, severity assessment, and regulatory implications. Adv Pharmacol 2019;85:165-93. [PMID: 31307586 DOI: 10.1016/bs.apha.2019.02.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
266 Lin NH, Yang HW, Su YJ, Chang CW. Herb induced liver injury after using herbal medicine: A systemic review and case-control study. Medicine (Baltimore). 2019;98:e14992. [PMID: 30921214 DOI: 10.1097/md.0000000000014992] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
267 Zhu Y, Niu M, Wang JB, Wang RL, Li JY, Ma YQ, Zhao YL, Zhang YF, He TT, Yu SM, Guo YM, Zhang F, Xiao XH, Schulze J. Predictors of poor outcomes in 488 patients with herb-induced liver injury. Turk J Gastroenterol. 2019;30:47-58. [PMID: 30289391 DOI: 10.5152/tjg.2018.17847] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
268 Laube R, Liu K. An unwanted complement: Rare case of potential liver injury induced by an interaction between ginseng and atorvastatin. Br J Clin Pharmacol 2019;85:1612-3. [PMID: 30980549 DOI: 10.1111/bcp.13927] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
269 Kishimoto M, Adachi M, Takahashi K, Washizaki K. Clonazepam-induced liver dysfunction, severe hyperlipidaemia, and hyperglycaemic crisis: A case report. SAGE Open Med Case Rep 2019;7:2050313X19842976. [PMID: 31001426 DOI: 10.1177/2050313X19842976] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
270 Huijbers A, Koggel LM, Bronkhorst C, Verheij J, Wanten GJA. Systematic Review: Noninvasive Assessments of Intestinal Failure–Associated Liver Disease in the Adult Population. Journal of Parenteral and Enteral Nutrition 2018;43:615-26. [DOI: 10.1002/jpen.1524] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
271 Ivashkin VT, Baranovsky AY, Raikhelson KL, Palgova LK, Maevskaya MV, Kondrashina EA, Marchenko NV, Nekrasova TP, Nikitin IG. Drug-Induced Liver Injuries (Clinical Guidelines for Physicians). Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2019;29:101-31. [DOI: 10.22416/1382-4376-2019-29-1-101-131] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
272 Kim B, Jo H. Administration Progression and Adverse Event Report of Er-Xian Decoction for Menopausal Hot Flushes: Case Report and Review of Literature. J Int Korean Med 2019;40:154-163. [DOI: 10.22246/jikm.2019.40.1.154] [Reference Citation Analysis]
273 Lin NH, Yang HW, Su YJ, Chang CW. Herb induced liver injury after using herbal medicine: A systemic review and case-control study. Medicine (Baltimore) 2019;98:e14992. [PMID: 30921214 DOI: 10.1097/MD.0000000000014992] [Reference Citation Analysis]
274 Gao Y, Wang Z, Tang J, Liu X, Shi W, Qin N, Wang X, Pang Y, Li R, Zhang Y, Wang J, Niu M, Bai Z, Xiao X. New incompatible pair of TCM: Epimedii Folium combined with Psoraleae Fructus induces idiosyncratic hepatotoxicity under immunological stress conditions. Front Med 2020;14:68-80. [PMID: 30924023 DOI: 10.1007/s11684-019-0690-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
275 Lee J, Shin J, Lee YJ, Kim M, Shin B, Lee J, Lee MS, Ha I. Battle Over Herb-Induced Liver Injury: Low Prevalence Confirmed through Secondary Evaluation and Research Team's Clarifying Rebuttal to Unwarranted Public Claims. The Journal of Alternative and Complementary Medicine 2019;25:260-4. [DOI: 10.1089/acm.2018.0253] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
276 Dusi N, Comacchio C, Lasalvia A. Late-Onset Cholestatic Liver Injury During Combination Treatment With Chlorpromazine and Olanzapine: A Case Report. J Clin Psychopharmacol 2019;39:175-6. [DOI: 10.1097/jcp.0000000000000999] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
277 He X, Zhang H, Tao B, Yang M, Chen H, Lu L, Yi H, Pan H, Tang S. The A/A Genotype of XPO1 rs4430924 Is Associated With Higher Risk of Antituberculosis Drug-Induced Hepatotoxicity in Chinese Patients. J Clin Pharmacol 2019;59:1014-21. [PMID: 30817003 DOI: 10.1002/jcph.1398] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
278 Stephens C, Lucena MI, Andrade RJ. Drug-Induced Liver Disease: Mechanism and Diagnosis. Evidence-based Gastroenterology and Hepatology 4e 2019. [DOI: 10.1002/9781119211419.ch47] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
279 Perumpail BJ, Li AA, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD. Diseases 2019;7:E27. [PMID: 30823570 DOI: 10.3390/diseases7010027] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
280 Pan H, Yang M, Lu L, Tao B, He X, Chen H, Yi H, Tang S. Association of FAM65B, AGBL4, and CUX2 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity: validation study in a Chinese Han population. Pharmacogenet Genomics 2019;29:84-90. [PMID: 30720667 DOI: 10.1097/FPC.0000000000000370] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
281 Fateh AH, Mohamed Z, Chik Z, Alsalahi A, Md Zain SR, Alshawsh MA. Mutagenicity and genotoxicity effects of Verbena officinalis leaves extract in Sprague-Dawley Rats. J Ethnopharmacol 2019;235:88-99. [PMID: 30738113 DOI: 10.1016/j.jep.2019.02.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
282 Meunier L, Ursic-bedoya J, Larrey D. Hepatopatías tóxicas medicamentosas y no medicamentosas: generalidades. EMC - Tratado de Medicina 2019;23:1-9. [DOI: 10.1016/s1636-5410(18)41698-4] [Reference Citation Analysis]
283 Wang Y, Wang L, Saxena R, Wee A, Yang R, Tian Q, Zhang J, Zhao X, Jia J. Clinicopathological features of He Shou Wu-induced liver injury: This ancient anti-aging therapy is not liver-friendly. Liver Int 2019;39:389-400. [PMID: 30066422 DOI: 10.1111/liv.13939] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
284 Wiebrecht A. 15 Jahre Centrum für Therapiesicherheit in der Chinesischen Arzneitherapie. Dtsch Z Akupunkt 2019;62:58-61. [DOI: 10.1007/s42212-018-0129-5] [Reference Citation Analysis]
285 Kwon J, Kim S, Yoo H, Lee E. Nimesulide-induced hepatotoxicity: A systematic review and meta-analysis. PLoS One 2019;14:e0209264. [PMID: 30677025 DOI: 10.1371/journal.pone.0209264] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
286 Jing J, Wang RL, Zhao XY, Zhu Y, Niu M, Wang LF, Song XA, He TT, Sun YQ, Xu WT, Yu SM, Wang LP, Guo YM, Bai ZF, Xiao XH, Wang JB. Association between the concurrence of pre-existing chronic liver disease and worse prognosis in patients with an herb- Polygonum multiflorum thunb. induced liver injury: a case-control study from a specialised liver disease center in China. BMJ Open. 2019;9:e023567. [PMID: 30782709 DOI: 10.1136/bmjopen-2018-023567] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
287 Byeon JH, Kil JH, Ahn YC, Son CG. Systematic review of published data on herb induced liver injury. J Ethnopharmacol. 2019;233:190-196. [PMID: 30639232 DOI: 10.1016/j.jep.2019.01.006] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 11.5] [Reference Citation Analysis]
288 Liao PF, Wu YK, Huang KL, Chen HY. A rare case of cefepime-induced cholestatic liver injury. Ci Ji Yi Xue Za Zhi 2019;31:124-8. [PMID: 31007494 DOI: 10.4103/tcmj.tcmj_151_18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
289 Duzenli T, Tanoglu A, Akyol T, Kara M, Yazgan Y. Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity. Euroasian J Hepatogastroenterol 2019;9:49-51. [PMID: 31988867 DOI: 10.5005/jp-journals-10018-1295] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
290 Song ZW, Pan YC, Huang ZC, Liu WX, Zhao RS, Jing HM, Dong F. Posaconazole-associated severe hyperbilirubinemia in acute myeloid leukemia following chemotherapy: A case report. World J Clin Cases 2018; 6(16): 1206-1209 [PMID: 30613684 DOI: 10.12998/wjcc.v6.i16.1206] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
291 Alfani R, Vassallo E, De Anseris AG, Nazzaro L, D'Acunzo I, Porfito C, Mandato C, Vajro P. Pediatric Fatty Liver and Obesity: Not Always Justa Matter of Non-Alcoholic Fatty Liver Disease. Children (Basel) 2018;5:E169. [PMID: 30551665 DOI: 10.3390/children5120169] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
292 Willson C. Sympathomimetic amine compounds and hepatotoxicity: Not all are alike-Key distinctions noted in a short review. Toxicol Rep 2019;6:26-33. [PMID: 30581759 DOI: 10.1016/j.toxrep.2018.11.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
293 Fu B, Wang N, Tan HY, Li S, Cheung F, Feng Y. Multi-Component Herbal Products in the Prevention and Treatment of Chemotherapy-Associated Toxicity and Side Effects: A Review on Experimental and Clinical Evidences. Front Pharmacol 2018;9:1394. [PMID: 30555327 DOI: 10.3389/fphar.2018.01394] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 11.2] [Reference Citation Analysis]
294 Teschke R. Alcoholic Liver Disease: Alcohol Metabolism, Cascade of Molecular Mechanisms, Cellular Targets, and Clinical Aspects. Biomedicines 2018;6:E106. [PMID: 30424581 DOI: 10.3390/biomedicines6040106] [Cited by in Crossref: 76] [Cited by in F6Publishing: 84] [Article Influence: 15.2] [Reference Citation Analysis]
295 Giacomelli A, Riva A, Falvella FS, Oreni ML, Cattaneo D, Cheli S, Renisi G, Di Cristo V, Lupo A, Clementi E, Rusconi S, Galli M, Ridolfo AL. Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy. BMC Infect Dis 2018;18:556. [PMID: 30419834 DOI: 10.1186/s12879-018-3462-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
296 Danan G, Teschke R. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch? Drug Saf. 2018;41:735-743. [PMID: 29502198 DOI: 10.1007/s40264-018-0654-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 10.2] [Reference Citation Analysis]
297 Teschke R. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.Expert Opin Drug Metab Toxicol. 2018;14:1169-1187. [PMID: 30354694 DOI: 10.1080/17425255.2018.1539077] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
298 Zhang C, Wang N, Xu Y, Tan HY, Li S, Feng Y. Molecular Mechanisms Involved in Oxidative Stress-Associated Liver Injury Induced by Chinese Herbal Medicine: An Experimental Evidence-Based Literature Review and Network Pharmacology Study. Int J Mol Sci 2018;19:E2745. [PMID: 30217028 DOI: 10.3390/ijms19092745] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
299 Bai Z, Li H, Guo X, Liu Y, Deng J, Wang C, Li Y, Qi X. Successful treatment of acute-on-chronic liver failure and hemolytic anemia with hepato-protective drugs in combination with intravenous ozone without steroids: A case report. Intractable Rare Dis Res 2018;7:204-8. [PMID: 30181943 DOI: 10.5582/irdr.2018.01074] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
300 Shamberg L, Vaziri H. Hepatotoxicity of Inflammatory Bowel Disease Medications. J Clin Gastroenterol 2018;52:674-84. [PMID: 30036242 DOI: 10.1097/MCG.0000000000001084] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
301 Lee H, Lee S, Kang JW, Lee J. Liver enzyme abnormalities of inpatients with rheumatic diseases: A 10-year retrospective study in a Korean medicine hospital. Phytotherapy Research 2018;32:1784-1794. [DOI: 10.1002/ptr.6111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
302 Li XL, Liu XC, Song YL, Hong RT, Shi H. Suspected drug-induced liver injury associated with iguratimod: a case report and review of the literature. BMC Gastroenterol 2018;18:130. [PMID: 30143001 DOI: 10.1186/s12876-018-0858-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
303 Becker MW, Lourençone EMS, De Mello AF, Branco A, Filho EMR, Blatt CR, Mallmann CA, Schneider M, Caregnato RCA, Blatt CR. Liver transplantation and the use of KAVA: Case report. Phytomedicine 2019;56:21-6. [PMID: 30668342 DOI: 10.1016/j.phymed.2018.08.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
304 Vincenzi B, Russo A, Terenzio A, Galvano A, Santini D, Vorini F, Antonelli-Incalzi R, Vespasiani-Gentilucci U, Tonini G. The use of SAMe in chemotherapy-induced liver injury. Crit Rev Oncol Hematol 2018;130:70-7. [PMID: 30196914 DOI: 10.1016/j.critrevonc.2018.06.019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
305 Licata A, Minissale MG. Weight-loss supplementation and acute liver failure: the case of Garcinia Cambogia. Intern Emerg Med 2018;13:833-5. [PMID: 30032342 DOI: 10.1007/s11739-018-1912-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
306 López-Riera M, Conde I, Quintas G, Pedrola L, Zaragoza Á, Perez-Rojas J, Salcedo M, Benlloch S, Castell JV, Jover R. Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers. Sci Rep 2018;8:10606. [PMID: 30006517 DOI: 10.1038/s41598-018-28854-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 7.8] [Reference Citation Analysis]
307 Dragoi D, Benesic A, Pichler G, Kulak NA, Bartsch HS, Gerbes AL. Proteomics Analysis of Monocyte-Derived Hepatocyte-Like Cells Identifies Integrin Beta 3 as a Specific Biomarker for Drug-Induced Liver Injury by Diclofenac. Front Pharmacol 2018;9:699. [PMID: 30022949 DOI: 10.3389/fphar.2018.00699] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
308 Philips CA, Paramaguru R, Augustine P. Reply to: Safety in Ayurveda-Need to bring the house in order by Dr. Sanjeev Rastogi. Indian J Gastroenterol 2018;37:376-7. [PMID: 30121888 DOI: 10.1007/s12664-018-0872-7] [Reference Citation Analysis]
309 Uçmak F, Tuncel ET, Kaçmaz H, Ebik B, Kaya M. Güneydoğu Anadolu Bölgesindeki Üçüncü Basamak Gastroenteroloji Kliniğinin Toksik Hepatit Deneyimi. Dicle Tıp Dergisi 2018. [DOI: 10.5798/dicletip.425003] [Reference Citation Analysis]
310 Teschke R, Wolff A, Eickhoff A, Danan G. Is obesity rather than the dietary supplement used for weight reduction the cause of liver injury? JGH Open 2018;2:152-7. [PMID: 30483581 DOI: 10.1002/jgh3.12057] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
311 Mahomoodally F, Suroowan S, Sreekeessoon U. Adverse reactions of herbal medicine—A quantitative assessment of severity in Mauritius. Journal of Herbal Medicine 2018;12:49-65. [DOI: 10.1016/j.hermed.2018.01.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
312 Teschke R, Danan G. Drug induced liver injury with analysis of alternative causes as confounding variables. Br J Clin Pharmacol 2018;84:1467-77. [PMID: 29607530 DOI: 10.1111/bcp.13593] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 6.4] [Reference Citation Analysis]
313 Taneja S, Kumar P, Rathi S, Duseja A, Singh V, Dhiman RK, Chawla YK. Acute Liver Failure Due to Etodolac, a Selective Cycloxygenase- 2 (COX -2) Inhibitor Non-Steroidal Anti-Inflammatory Drug Established by RUCAM-Based Causality Assessment. Ann Hepatol 2017;16:818-21. [PMID: 28809737 DOI: 10.5604/01.3001.0010.2829] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
314 Teschke R. Alcoholic steatohepatitis (ASH) and alcoholic hepatitis (AH): cascade of events, clinical aspects, and pharmacotherapy options. Expert Opin Pharmacother 2018;19:779-93. [PMID: 29708448 DOI: 10.1080/14656566.2018.1465929] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
315 Hunt CM. Expanding our toolkit to better identify drug-induced liver injury in electronic medical records. Liver Int 2018;38:585-7. [PMID: 29575769 DOI: 10.1111/liv.13710] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
316 Szántová M, Sedlačko J, Jakabovičová M. Drug and herbal hepatotoxicity: an overview of clinical classifications. Vnitr Lek 2018;64:384-393. [DOI: 10.36290/vnl.2018.057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
317 Kothadia JP, Kaminski M, Samant H, Olivera-Martinez M. Hepatotoxicity Associated with Use of the Weight Loss Supplement Garcinia cambogia: A Case Report and Review of the Literature. Case Reports Hepatol. 2018;2018:6483605. [PMID: 29721342 DOI: 10.1155/2018/6483605] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
318 Meunier L, Larrey D. Recent Advances in Hepatotoxicity of Non Steroidal Anti-Inflammatory Drugs. Ann Hepatol 2018;17:187-91. [PMID: 29469052 DOI: 10.5604/01.3001.0010.8633] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
319 Teschke R, Eickhoff A, Wolff A, Xuan TD. Liver Injury from Herbs and “Dietary Supplements”: Highlights of a Literature Review from 2015 to 2017. Curr Pharmacol Rep 2018;4:120-31. [DOI: 10.1007/s40495-018-0124-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 2.4] [Reference Citation Analysis]
320 Scalfaro E, Streefkerk HJ, Merz M, Meier C, Lewis D. Preliminary Results of a Novel Algorithmic Method Aiming to Support Initial Causality Assessment of Routine Pharmacovigilance Case Reports for Medication-Induced Liver Injury: The PV-RUCAM. Drug Saf 2017;40:715-27. [PMID: 28508325 DOI: 10.1007/s40264-017-0541-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
321 Awortwe C, Makiwane M, Reuter H, Muller C, Louw J, Rosenkranz B. Critical evaluation of causality assessment of herb-drug interactions in patients. Br J Clin Pharmacol 2018;84:679-93. [PMID: 29363155 DOI: 10.1111/bcp.13490] [Cited by in Crossref: 70] [Cited by in F6Publishing: 74] [Article Influence: 14.0] [Reference Citation Analysis]
322 Zhang Q, Li Y, Liu M, Duan J, Zhou X, Zhu H. Compatibility with Panax notoginseng and Rehmannia glutinosa Alleviates the Hepatotoxicity and Nephrotoxicity of Tripterygium wilfordii via Modulating the Pharmacokinetics of Triptolide. Int J Mol Sci 2018;19:E305. [PMID: 29351251 DOI: 10.3390/ijms19010305] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
323 Wang R, Qi X, Yoshida EM, Méndez-Sánchez N, Teschke R, Sun M, Liu X, Su C, Deng J, Deng H, Hou F, Guo X. Clinical characteristics and outcomes of traditional Chinese medicine-induced liver injury: a systematic review. Expert Rev Gastroenterol Hepatol 2018;12:425-34. [PMID: 29323538 DOI: 10.1080/17474124.2018.1427581] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
324 Teschke R, Danan G. Causality Assessment Methods in Drug-Induced Liver Injury. Methods in Pharmacology and Toxicology 2018. [DOI: 10.1007/978-1-4939-7677-5_27] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
325 Daly AK. Human Leukocyte Antigen (HLA) and Other Genetic Risk Factors in Drug-Induced Liver Injury (DILI). Methods in Pharmacology and Toxicology 2018. [DOI: 10.1007/978-1-4939-7677-5_24] [Reference Citation Analysis]
326 Avigan MI, Muñoz MA. Perspectives on the Regulatory and Clinical Science of Drug-Induced Liver Injury (DILI). Methods in Pharmacology and Toxicology 2018. [DOI: 10.1007/978-1-4939-7677-5_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
327 Tao B, Chen S, Lin G, Yang M, Lu L, He X, Pan H, Tang S. Genetic polymorphisms of UGT1A1 and susceptibility to anti-tuberculosis drug-induced liver: A RUCAM-based case–control study. Int J Immunopathol Pharmacol 2018;32:205873841881628. [DOI: 10.1177/2058738418816288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
328 Teschke R, Danan G. Diagnosis and Management of Drug-Induced Liver Injury (DILI) in Patients with Pre-Existing Liver Disease. Drug Saf. 2016;39:729-744. [PMID: 27091053 DOI: 10.1007/s40264-016-0423-z] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
329 Chacko KR, Wolkoff AW. Intrahepatic Cholestasis of Pregnancy: New Diagnostic Insights. Ann Hepatol 2017;16:176-8. [PMID: 28233755 DOI: 10.5604/16652681.1231594] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
330 Teschke R, Danan G. Prospective Indian Study of DILI with Confirmed Causality Using the Roussel Uclaf Causality Assessment Method (RUCAM): A report of Excellence. Ann Hepatol 2017;16:324-5. [PMID: 28425398 DOI: 10.5604/16652681.1235471] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
331 Gharia B, Seegobin K, Maharaj S, Marji N, Deutch A, Zuberi L. Letrozole-induced hepatitis with autoimmune features: a rare adverse drug reaction with review of the relevant literature. Oxf Med Case Reports 2017;2017:omx074. [PMID: 29230302 DOI: 10.1093/omcr/omx074] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
332 Brewer CT, Chen T. Hepatotoxicity of Herbal Supplements Mediated by Modulation of Cytochrome P450. Int J Mol Sci 2017;18:E2353. [PMID: 29117101 DOI: 10.3390/ijms18112353] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 8.2] [Reference Citation Analysis]
333 Jing J, Teschke R. Traditional Chinese Medicine and Herb-induced Liver Injury: Comparison with Drug-induced Liver Injury. J Clin Transl Hepatol 2018;6:57-68. [PMID: 29577033 DOI: 10.14218/JCTH.2017.00033] [Cited by in Crossref: 43] [Cited by in F6Publishing: 51] [Article Influence: 7.2] [Reference Citation Analysis]
334 Kesavarapu K, Kang M, Shin JJ, Rothstein K. Yogi Detox Tea: A Potential Cause of Acute Liver Failure. Case Rep Gastrointest Med. 2017;2017:3540756. [PMID: 29204300 DOI: 10.1155/2017/3540756] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
335 Lammel-Lindemann JA, Flores-Villalba E, Martagón AJ, DeObeso-Gonzalez E, Puente-Gallegos F. Noncholestatic acute hepatocellular injury following candesartan administration. Br J Clin Pharmacol 2018;84:204-7. [PMID: 28841231 DOI: 10.1111/bcp.13406] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
336 Melchart D, Hager S, Albrecht S, Dai J, Weidenhammer W, Teschke R. Herbal Traditional Chinese Medicine and suspected liver injury: A prospective study. World J Hepatol 2017; 9(29): 1141-1157 [PMID: 29085558 DOI: 10.4254/wjh.v9.i29.1141] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 7.5] [Reference Citation Analysis]
337 Shahbaz O, Mahajan S, Lewis JH. Highlights of Drug - and Herb- induced liver injury in the Literature from 2016: How Best to Translate New Information into Clinical Practice? Expert Opin Drug Metab Toxicol. 2017;13:935-951. [PMID: 28772086 DOI: 10.1080/17425255.2017.1362391] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
338 Hai Y, Feng S, Wang L, Ma Y, Zhai Y, Wu Z, Zhang S, He X. Coordination Mechanism and Bio-Evidence: Reactive γ-Ketoenal Intermediated Hepatotoxicity of Psoralen and Isopsoralen Based on Computer Approach and Bioassay. Molecules 2017;22:E1451. [PMID: 32962321 DOI: 10.3390/molecules22091451] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
339 López-Gil S, Nuño-Lámbarri N, Chávez-Tapia N, Uribe M, Barbero-Becerra VJ. Liver toxicity mechanisms of herbs commonly used in Latin America. Drug Metab Rev 2017;49:338-56. [PMID: 28571502 DOI: 10.1080/03602532.2017.1335750] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
340 Kim JH, Nam WS, Kim SJ, Kwon OK, Seung EJ, Jo JJ, Shresha R, Lee TH, Jeon TW, Ki SH, Lee HS, Lee S. Mechanism Investigation of Rifampicin-Induced Liver Injury Using Comparative Toxicoproteomics in Mice. Int J Mol Sci 2017;18:E1417. [PMID: 28671602 DOI: 10.3390/ijms18071417] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
341 McEuen K, Borlak J, Tong W, Chen M. Associations of Drug Lipophilicity and Extent of Metabolism with Drug-Induced Liver Injury.Int J Mol Sci. 2017;18. [PMID: 28640208 DOI: 10.3390/ijms18071335] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 6.8] [Reference Citation Analysis]
342 Lin L, Li H, Lin H, Zhang M, Qu C, Yan L, Yin X, Ni J. A New Perspective on Liver Injury by Traditional Chinese Herbs Such As Polygonum multiflorum: The Geographical Area of Harvest As an Important Contributory Factor. Front Pharmacol 2017;8:349. [PMID: 28676759 DOI: 10.3389/fphar.2017.00349] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
343 Kullak-Ublick GA, Andrade RJ, Merz M, End P, Benesic A, Gerbes AL, Aithal GP. Drug-induced liver injury: recent advances in diagnosis and risk assessment. Gut 2017;66:1154-64. [PMID: 28341748 DOI: 10.1136/gutjnl-2016-313369] [Cited by in Crossref: 266] [Cited by in F6Publishing: 255] [Article Influence: 44.3] [Reference Citation Analysis]
344 Yuan D, Yang X, Guo JC. A great honor and a huge challenge for China: You-you TU getting the Nobel Prize in Physiology or Medicine. J Zhejiang Univ Sci B 2016;17:405-8. [PMID: 27143269 DOI: 10.1631/jzus.B1600094] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
345 Li DK, Chen J, Ge ZZ, Sun ZX. Hepatotoxicity in Rats Induced by Aqueous Extract of Polygoni Multiflori Radix, Root of Polygonum multiflorum Related to the Activity Inhibition of CYP1A2 or CYP2E1. Evid Based Complement Alternat Med 2017;2017:9456785. [PMID: 28626488 DOI: 10.1155/2017/9456785] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
346 Li C, He Q, Gao D, Li R, Zhu Y, Li H, Feng W, Yang M, Xiao X, Wang J. Idiosyncratic drug-induced liver injury linked to Polygonum multiflorum: A case study by pharmacognosy. Chin J Integr Med 2017;23:625-30. [DOI: 10.1007/s11655-017-2543-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
347 Iorga A, Dara L, Kaplowitz N. Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis. Int J Mol Sci. 2017;18. [PMID: 28486401 DOI: 10.3390/ijms18051018] [Cited by in Crossref: 130] [Cited by in F6Publishing: 138] [Article Influence: 21.7] [Reference Citation Analysis]
348 Terziroli Beretta-Piccoli B, Mieli-Vergani G, Bertoli R, Mazzucchelli L, Nofziger C, Paulmichl M, Vergani D. Atovaquone/proguanil-induced autoimmune-like hepatitis. Hepatol Commun 2017;1:293-8. [PMID: 29404460 DOI: 10.1002/hep4.1039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
349 Yu YC, Mao YM, Chen CW, Chen JJ, Chen J, Cong WM, Ding Y, Duan ZP, Fu QC, Guo XY, Hu P, Hu XQ, Jia JD, Lai RT, Li DL, Liu YX, Lu LG, Ma SW, Ma X, Nan YM, Ren H, Shen T, Wang H, Wang JY, Wang TL, Wang XJ, Wei L, Xie Q, Xie W, Yang CQ, Yang DL, Yu YY, Zeng MD, Zhang L, Zhao XY, Zhuang H;  Drug-induced Liver Injury (DILI) Study Group;  Chinese Society of Hepatology (CSH);  Chinese Medical Association (CMA). CSH guidelines for the diagnosis and treatment of drug-induced liver injury. Hepatol Int. 2017;11:221-241. [PMID: 28405790 DOI: 10.1007/s12072-017-9793-2] [Cited by in Crossref: 140] [Cited by in F6Publishing: 153] [Article Influence: 23.3] [Reference Citation Analysis]
350 Teschke R, Schulze J, Eickhoff A, Danan G. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment? Int J Mol Sci. 2017;18:E803. [PMID: 28398242 DOI: 10.3390/ijms18040803] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 7.2] [Reference Citation Analysis]
351 Vliegenthart ADB, Berends C, Potter CMJ, Kersaudy-Kerhoas M, Dear JW. MicroRNA-122 can be measured in capillary blood which facilitates point-of-care testing for drug-induced liver injury. Br J Clin Pharmacol 2017;83:2027-33. [PMID: 28257154 DOI: 10.1111/bcp.13282] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 4.5] [Reference Citation Analysis]
352 Teschke R, Eickhoff A. Suspected Liver Injury and the Dilemma of Causality. Dig Dis Sci 2017;62:1095-8. [PMID: 28210906 DOI: 10.1007/s10620-016-4442-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
353 Svedlund E, Larsson M, Hägerkvist R. Spontaneously Reported Adverse Reactions for Herbal Medicinal Products and Natural Remedies in Sweden 2007-15: Report from the Medical Products Agency. Drugs Real World Outcomes 2017;4:119-25. [PMID: 28353157 DOI: 10.1007/s40801-017-0104-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
354 Abbara A, Chitty S, Roe JK, Ghani R, Collin SM, Ritchie A, Kon OM, Dzvova J, Davidson H, Edwards TE, Hateley C, Routledge M, Buckley J, Davidson RN, John L. Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK. BMC Infect Dis 2017;17:231. [PMID: 28340562 DOI: 10.1186/s12879-017-2330-z] [Cited by in Crossref: 44] [Cited by in F6Publishing: 50] [Article Influence: 7.3] [Reference Citation Analysis]
355 Palgova LK, Borisova IV, Zhestkova NV, Tarasova MA. Essential phospholipids use in the treatment of drug-induced liver injury in pregnant women. Z akus zen bolezn 2017;66:14-23. [DOI: 10.17816/jowd66214-23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
356 Kim JH, Choi WG, Lee S, Lee HS. Revisiting the Metabolism and Bioactivation of Ketoconazole in Human and Mouse Using Liquid Chromatography-Mass Spectrometry-Based Metabolomics. Int J Mol Sci 2017;18:E621. [PMID: 28335386 DOI: 10.3390/ijms18030621] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
357 Vickers AE, Ulyanov AV, Fisher RL. Liver Effects of Clinical Drugs Differentiated in Human Liver Slices. Int J Mol Sci 2017;18:E574. [PMID: 28272341 DOI: 10.3390/ijms18030574] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
358 Wiebrecht A. Fragwürdige Pseudowissenschaft – zur angeblichen Hepatotoxizität chinesischer Arzneimittel. Chinese Medicine 2017;32:25-31. [DOI: 10.1007/s00052-017-0135-1] [Reference Citation Analysis]
359 Shehu AI, Ma X, Venkataramanan R. Mechanisms of Drug-Induced Hepatotoxicity. Clin Liver Dis 2017;21:35-54. [PMID: 27842774 DOI: 10.1016/j.cld.2016.08.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 6.5] [Reference Citation Analysis]
360 Tsang L, Fadia M, Chitturi S. A Time to Pause and Reflect: When a Patient with Autoimmune Hepatitis Stops Responding to Corticosteroids. Case Rep Gastrointest Med 2016;2016:7092434. [PMID: 28116182 DOI: 10.1155/2016/7092434] [Reference Citation Analysis]
361 Raschi E, De Ponti F. Drug-induced liver injury: Towards early prediction and risk stratification. World J Hepatol 2017; 9(1): 30-37 [PMID: 28105256 DOI: 10.4254/wjh.v9.i1.30] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
362 Bellanger RA, Seeger CM, Smith HE. Safety of Complementary and Alternative Medicine (CAM) Treatments and Practices. Side Effects of Drugs Annual 2017. [DOI: 10.1016/bs.seda.2017.06.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
363 Teschke R, Danan G. Drug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue? Expert Opin Drug Metab Toxicol. 2017;13:425-438. [PMID: 27822971 DOI: 10.1080/17425255.2017.1252749] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
364 Wu YL, Lian LH, Nan JX. Protective effects of Chinese traditional medicine against liver injury and liver fibrosis and mechanisms involved. Shijie Huaren Xiaohua Zazhi 2016; 24(30): 4144-4150 [DOI: 10.11569/wcjd.v24.i30.4144] [Reference Citation Analysis]
365 Sobhonslidsuk A, Poovorawan K, Soonthornworasiri N, Pan-Ngum W, Phaosawasdi K. The incidence, presentation, outcomes, risk of mortality and economic data of drug-induced liver injury from a national database in Thailand: a population-base study. BMC Gastroenterol 2016;16:135. [PMID: 27793116 DOI: 10.1186/s12876-016-0550-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
366 Zhang W, Chen L, Shen Y, Xu J. Rifampicin-induced injury in L02 cells is alleviated by 4-PBA via inhibition of the PERK-ATF4-CHOP pathway. Toxicology in Vitro 2016;36:186-96. [DOI: 10.1016/j.tiv.2016.07.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
367 Unger C, Al-Jashaami LS. Ciprofloxacin Exposure Leading to Fatal Hepatotoxicity: An Unusual Correlation. Am J Case Rep 2016;17:676-81. [PMID: 27653941 DOI: 10.12659/ajcr.899080] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
368 Teschke R, Schwarzenboeck A, Frenzel C, Schulze J, Eickhoff A, Wolff A. The mystery of the Hawaii liver disease cluster in summer 2013: A pragmatic and clinical approach to solve the problem. Ann Hepatol 2016;15:91-109. [PMID: 26626645 DOI: 10.5604/16652681.1184237] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
369 Lee SY, Ryu SH, Kim HG, Ryoo DW, Kim SJ, Jeong SM, Goo BH, Kim MJ, Park YC, Baek YH, Nam SS, Seo BK. 한방 복합치료를 시행한 임신 중 요통 환자 치험 3례. The Acupuncture 2016;33:197-205. [DOI: 10.13045/acupunct.2016047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
370 Teschke R, Andrade RJ. Drug, Herb, and Dietary Supplement Hepatotoxicity. Int J Mol Sci 2016;17:E1488. [PMID: 27608014 DOI: 10.3390/ijms17091488] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
371 Zhang P, Ye Y, Yang X, Jiao Y. Systematic Review on Chinese Herbal Medicine Induced Liver Injury. Evid Based Complement Alternat Med. 2016;2016:3560812. [PMID: 27651817 DOI: 10.1155/2016/3560812] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
372 Teschke R, Larrey D, Melchart D, Danan G. Traditional Chinese Medicine (TCM) and herbal hepatotoxicity: RUCAM and the role of novel diagnostic biomarkers such as microRNAs. Medicines. 2016;3:18. [PMID: 28930128 DOI: 10.3390/medicines3030018] [Cited by in Crossref: 55] [Cited by in F6Publishing: 66] [Article Influence: 7.9] [Reference Citation Analysis]
373 Zhu L, Chen X, Kong X, Cai YD. Investigation of the roles of trace elements during hepatitis C virus infection using protein-protein interactions and a shortest path algorithm. Biochim Biophys Acta 2016;1860:2756-68. [PMID: 27208424 DOI: 10.1016/j.bbagen.2016.05.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
374 Ortega-Alonso A, Stephens C, Lucena MI, Andrade RJ. Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury. Int J Mol Sci. 2016;17. [PMID: 27187363 DOI: 10.3390/ijms17050714] [Cited by in Crossref: 51] [Cited by in F6Publishing: 58] [Article Influence: 7.3] [Reference Citation Analysis]
375 Frenzel C, Teschke R. Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation. Int J Mol Sci. 2016;17:pii: E588. [PMID: 27128912 DOI: 10.3390/ijms17050588] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 10.9] [Reference Citation Analysis]
376 Pantano F, Tittarelli R, Mannocchi G, Zaami S, Ricci S, Giorgetti R, Terranova D, Busardò FP, Marinelli E. Hepatotoxicity Induced by "the 3Ks": Kava, Kratom and Khat. Int J Mol Sci 2016;17:580. [PMID: 27092496 DOI: 10.3390/ijms17040580] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 8.6] [Reference Citation Analysis]
377 Papafragkakis C, Ona MA, Reddy M, Anand S. Acute Hepatitis after Ingestion of a Preparation of Chinese Skullcap and Black Catechu for Joint Pain. Case Reports Hepatol. 2016;2016:4356749. [PMID: 27144042 DOI: 10.1155/2016/4356749] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
378 Teschke R, Eickhoff A. The Honolulu Liver Disease Cluster at the Medical Center: Its Mysteries and Challenges. Int J Mol Sci. 2016;17:476. [PMID: 27043544 DOI: 10.3390/ijms17040476] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
379 Wu Y, Geng XC, Wang JF, Miao YF, Lu YL, Li B. The HepaRG cell line, a superior in vitro model to L-02, HepG2 and hiHeps cell lines for assessing drug-induced liver injury. Cell Biol Toxicol 2016;32:37-59. [PMID: 27027780 DOI: 10.1007/s10565-016-9316-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 6.4] [Reference Citation Analysis]
380 Lüde S, Vecchio S, Sinno-Tellier S, Dopter A, Mustonen H, Vucinic S, Jonsson B, Müller D, Veras Gimenez Fruchtengarten L, Hruby K, De Souza Nascimento E, Di Lorenzo C, Restani P, Kupferschmidt H, Ceschi A. Adverse Effects of Plant Food Supplements and Plants Consumed as Food: Results from the Poisons Centres-Based PlantLIBRA Study. Phytother Res 2016;30:988-96. [PMID: 26948409 DOI: 10.1002/ptr.5604] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
381 Björnsson ES. Hepatotoxicity by Drugs: The Most Common Implicated Agents. Int J Mol Sci. 2016;17:224. [PMID: 26861310 DOI: 10.3390/ijms17020224] [Cited by in Crossref: 131] [Cited by in F6Publishing: 135] [Article Influence: 18.7] [Reference Citation Analysis]
382 Teschke R, Zhang L, Long H, Schwarzenboeck A, Schmidt-taenzer W, Genthner A, Wolff A, Frenzel C, Schulze J, Eickhoff A, Wiebrecht A. Traditional Chinese Medicine and herbal hepatotoxicity: a tabular compilation of reported cases. Deutsche Zeitschrift für Akupunktur 2016;59:33-35. [DOI: 10.1016/s0415-6412(16)30121-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]